|
1
|
Sparaco R, Cinque P, Scognamiglio A, Corvino A, Caliendo G, Fiorino F, Magli E, Perissutti E, Santagada V, Severino B, Luciano P, Casertano M, Aiello A, Martins Viegas GY, De Nucci G, Frecentese F. 3-Nitroatenolol: First Synthesis, Chiral Resolution and Enantiomers' Absolute Configuration. Molecules 2024; 29:1598. [PMID: 38611877 PMCID: PMC11013601 DOI: 10.3390/molecules29071598] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2024] [Revised: 03/26/2024] [Accepted: 03/27/2024] [Indexed: 04/14/2024] Open
Abstract
4-Nitro and 7-nitro propranolol have been recently synthesized and characterized by us. (±)-4-NO2-propranolol has been shown to act as a selective antagonist of 6-nitrodopamine (6-ND) receptors in the right atrium of rats. As part of our follow-up to this study, herein, we describe the first synthesis of (±)-3-nitroatenolol as a probe to evaluate the potential nitration of atenolol by endothelium. Chiral chromatography was used to produce pure enantiomers. By using Riguera's method, which is based on the sign distribution of ΔδH, the absolute configuration of the secondary alcohol was determined.
Collapse
Affiliation(s)
- Rosa Sparaco
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy; (R.S.); (P.C.); (A.S.); (A.C.); (G.C.); (F.F.); (E.P.); (V.S.); (B.S.); (P.L.); (M.C.); (A.A.); (F.F.)
| | - Pierfrancesco Cinque
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy; (R.S.); (P.C.); (A.S.); (A.C.); (G.C.); (F.F.); (E.P.); (V.S.); (B.S.); (P.L.); (M.C.); (A.A.); (F.F.)
| | - Antonia Scognamiglio
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy; (R.S.); (P.C.); (A.S.); (A.C.); (G.C.); (F.F.); (E.P.); (V.S.); (B.S.); (P.L.); (M.C.); (A.A.); (F.F.)
| | - Angela Corvino
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy; (R.S.); (P.C.); (A.S.); (A.C.); (G.C.); (F.F.); (E.P.); (V.S.); (B.S.); (P.L.); (M.C.); (A.A.); (F.F.)
| | - Giuseppe Caliendo
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy; (R.S.); (P.C.); (A.S.); (A.C.); (G.C.); (F.F.); (E.P.); (V.S.); (B.S.); (P.L.); (M.C.); (A.A.); (F.F.)
| | - Ferdinando Fiorino
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy; (R.S.); (P.C.); (A.S.); (A.C.); (G.C.); (F.F.); (E.P.); (V.S.); (B.S.); (P.L.); (M.C.); (A.A.); (F.F.)
| | - Elisa Magli
- Department of Public Health, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy;
| | - Elisa Perissutti
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy; (R.S.); (P.C.); (A.S.); (A.C.); (G.C.); (F.F.); (E.P.); (V.S.); (B.S.); (P.L.); (M.C.); (A.A.); (F.F.)
| | - Vincenzo Santagada
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy; (R.S.); (P.C.); (A.S.); (A.C.); (G.C.); (F.F.); (E.P.); (V.S.); (B.S.); (P.L.); (M.C.); (A.A.); (F.F.)
| | - Beatrice Severino
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy; (R.S.); (P.C.); (A.S.); (A.C.); (G.C.); (F.F.); (E.P.); (V.S.); (B.S.); (P.L.); (M.C.); (A.A.); (F.F.)
| | - Paolo Luciano
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy; (R.S.); (P.C.); (A.S.); (A.C.); (G.C.); (F.F.); (E.P.); (V.S.); (B.S.); (P.L.); (M.C.); (A.A.); (F.F.)
| | - Marcello Casertano
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy; (R.S.); (P.C.); (A.S.); (A.C.); (G.C.); (F.F.); (E.P.); (V.S.); (B.S.); (P.L.); (M.C.); (A.A.); (F.F.)
| | - Anna Aiello
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy; (R.S.); (P.C.); (A.S.); (A.C.); (G.C.); (F.F.); (E.P.); (V.S.); (B.S.); (P.L.); (M.C.); (A.A.); (F.F.)
| | - Gustavo Yuri Martins Viegas
- Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas (UNICAMP), Campinas 13083-887, SP, Brazil;
- Department of Health Studies, Metropolitan University of Santos (UNIMES), Santos 11045-002, SP, Brazil
| | - Gilberto De Nucci
- Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas (UNICAMP), Campinas 13083-887, SP, Brazil;
- Department of Health Studies, Metropolitan University of Santos (UNIMES), Santos 11045-002, SP, Brazil
| | - Francesco Frecentese
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy; (R.S.); (P.C.); (A.S.); (A.C.); (G.C.); (F.F.); (E.P.); (V.S.); (B.S.); (P.L.); (M.C.); (A.A.); (F.F.)
| |
Collapse
|
|
2
|
Andreozzi G, Ambrosio MR, Magli E, Maneli G, Severino B, Corvino A, Sparaco R, Perissutti E, Frecentese F, Santagada V, Leśniak A, Bujalska-Zadrożny M, Caliendo G, Formisano P, Fiorino F. Design, Synthesis and Biological Evaluation of Novel N-Arylpiperazines Containing a 4,5-Dihydrothiazole Ring. Pharmaceuticals (Basel) 2023; 16:1483. [PMID: 37895954 PMCID: PMC10609883 DOI: 10.3390/ph16101483] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2023] [Revised: 10/03/2023] [Accepted: 10/16/2023] [Indexed: 10/29/2023] Open
Abstract
Arylpiperazines represent one of the most important classes of 5-HT1AR ligands and have attracted considerable interests for their versatile properties in chemistry and pharmacology, leading to the research of new derivatives that has been focused on the modification of one or more portions of such pharmacophore. An efficient protocol for the synthesis of novel thiazolinylphenyl-piperazines (2a-c) and the corresponding acetylated derivatives was used (3a-c). The new compounds were tested for their functional activity and affinity at 5-HT1A receptors, showing an interesting affinity profile with a Ki value of 412 nM for compound 2b. The cytotoxic activity of novel thiazolinylphenyl-piperazines (2a-c) and corresponding N-acetyl derivatives (3a-c) against human prostate and breast cancer cell lines (LNCAP, DU-145 and PC-3, MCF-7, SKBR-3 and MDA-MB231) was investigated according to the procedure described in the literature. The reported data showed a cytotoxic effect for 2a-c and 3a-c compounds (IC50 values ranging from 15 µM to 73 µM) on the investigated cancer cell lines, with no effect on noncancer cells. Future studies will be aimed to investigate the mechanism of action and therapeutic prospects of these new scaffolds.
Collapse
Affiliation(s)
- Giorgia Andreozzi
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| | - Maria Rosaria Ambrosio
- URT “Genomic of Diabetes”, Institute for Experimental Endocrinology and Oncology “G. Salvatore”, National Research Council (IEOS-CNR), Via Pansini 5, 80131 Naples, Italy; (M.R.A.); (P.F.)
| | - Elisa Magli
- Dipartimento di Sanità Pubblica, Università di Napoli Federico II, Via Pansini, 5, 80131, Naples, Italy;
| | - Giovanni Maneli
- Department of Translational Medicine, University of Naples “Federico II”, Via Pansini 5, 80131 Naples, Italy;
| | - Beatrice Severino
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| | - Angela Corvino
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| | - Rosa Sparaco
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| | - Elisa Perissutti
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| | - Francesco Frecentese
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| | - Vincenzo Santagada
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| | - Anna Leśniak
- Department of Pharmacotherapy and Pharmaceutical Care, Centre for Preclinical Research and Technology, Faculty of Pharmacy, Medical University of Warsaw, 1 Banacha Str., 02-097 Warsaw, Poland; (A.L.); (M.B.-Z.)
| | - Magdalena Bujalska-Zadrożny
- Department of Pharmacotherapy and Pharmaceutical Care, Centre for Preclinical Research and Technology, Faculty of Pharmacy, Medical University of Warsaw, 1 Banacha Str., 02-097 Warsaw, Poland; (A.L.); (M.B.-Z.)
| | - Giuseppe Caliendo
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| | - Pietro Formisano
- URT “Genomic of Diabetes”, Institute for Experimental Endocrinology and Oncology “G. Salvatore”, National Research Council (IEOS-CNR), Via Pansini 5, 80131 Naples, Italy; (M.R.A.); (P.F.)
- Department of Translational Medicine, University of Naples “Federico II”, Via Pansini 5, 80131 Naples, Italy;
| | - Ferdinando Fiorino
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| |
Collapse
|
|
3
|
Cerqua I, Granato E, Corvino A, Severino B, D’Avino D, Simonelli M, Perissutti E, Scognamiglio A, Mirra D, D’Agostino B, Caliendo G, Rossi A, Cirino G, Motta CM, Roviezzo F. Prednisone-hydrogen sulfide releasing hybrid shows improved therapeutic profile in asthma. Front Pharmacol 2023; 14:1266934. [PMID: 37900172 PMCID: PMC10602694 DOI: 10.3389/fphar.2023.1266934] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2023] [Accepted: 09/28/2023] [Indexed: 10/31/2023] Open
Abstract
Introduction: Hydrogen sulfide (H2S) is emerging as an important potential therapeutic option for respiratory inflammatory diseases. In this study, we investigated the effectiveness of a novel corticosteroid derivative, that is chemically linked to an H2S donor, in managing asthma features. Methods: The effects of prednisone (PS), H2S donor (4-hydroxybenzamide; TBZ), and their combination (PS-TBZ) have been evaluated in vitro and in vivo. The in vitro experiments were conducted using lipopolysaccharidestimulated J774 macrophages, while the in vivo experiments utilizing an experimental asthma model. Results: In the in vitro study we found that PS-TBZ exhibited an increased effect compared to the individual parent compounds in modulating the production of inflammatory mediators. TBZ also significantly reduced bronchial contractility and enhanced bronchial relaxation. In the in vivo experiments, where we administered PS, TBZ, or PS-TBZ to ovalbumin-sensitized BALB/c mice, we confirmed that PS-TBZ had a significantly better action in controlling airway hyperreactivity as compared to TBZ or PS alone. Moreover, PS-TBZ was more effective in restoring salbutamol-induced relaxation. The immunohistochemistry analysis demonstrated a significant reduction in the production of α-SMA and procollagen III, indicating the efficacy of PS-TBZ in controlling airway remodeling. Moreover, PS-TBZ also promoted epithelial repair, recovery of the bronchial and parenchyma structure and inhibited mucin production. Discussion: In conclusion, PS-TBZ offers an important opportunity to optimize the beneficial impact of corticosteroids on asthma features.
Collapse
Affiliation(s)
- Ida Cerqua
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Campania, Italy
| | - Elisabetta Granato
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Campania, Italy
| | - Angela Corvino
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Campania, Italy
| | - Beatrice Severino
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Campania, Italy
| | - Danilo D’Avino
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Campania, Italy
| | - Martina Simonelli
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Campania, Italy
| | - Elisa Perissutti
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Campania, Italy
| | - Antonia Scognamiglio
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Campania, Italy
| | - Davida Mirra
- Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania Luigi Vanvitelli, Caserta, Campania, Italy
| | - Bruno D’Agostino
- Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania Luigi Vanvitelli, Caserta, Campania, Italy
| | - Giuseppe Caliendo
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Campania, Italy
| | - Antonietta Rossi
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Campania, Italy
| | - Giuseppe Cirino
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Campania, Italy
| | - Chiara Maria Motta
- Department of Biology, Polytechnic and Basic Sciences School, University of Naples Federico II, Naples, Campania, Italy
| | - Fiorentina Roviezzo
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Campania, Italy
| |
Collapse
|
|
4
|
Sparaco R, Scognamiglio A, Corvino A, Caliendo G, Fiorino F, Magli E, Perissutti E, Santagada V, Severino B, Luciano P, Casertano M, Aiello A, De Nucci G, Frecentese F. Synthesis, Chiral Resolution and Enantiomers Absolute Configuration of 4-Nitropropranolol and 7-Nitropropranolol. Molecules 2022; 28:molecules28010057. [PMID: 36615252 PMCID: PMC9822233 DOI: 10.3390/molecules28010057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2022] [Revised: 12/06/2022] [Accepted: 12/15/2022] [Indexed: 12/24/2022] Open
Abstract
We recently identified 6-nitrodopamine and other nitro-catecholamines (6-nitrodopa, 6-nitroadrenaline), indicating that the endothelium has the ability to nitrate the classical catecholamines (dopamine, noradrenaline, and adrenaline). In order to investigate whether drugs could be subject to the same nitration process, we synthesized 4-nitro- and 7-nitropropranolol as probes to evaluate the possible nitration of the propranolol by the endothelium. The separation of the enantiomers in very high yields and excellent enantiopurity was achieved by chiral HPLC. Finally, we used Riguera's method to determine the absolute configuration of the enantiomers, through double derivatization with MPA and NMR studies.
Collapse
Affiliation(s)
- Rosa Sparaco
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy
| | - Antonia Scognamiglio
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy
| | - Angela Corvino
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy
| | - Giuseppe Caliendo
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy
| | - Ferdinando Fiorino
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy
| | - Elisa Magli
- Department of Public Health, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy
| | - Elisa Perissutti
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy
| | - Vincenzo Santagada
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy
| | - Beatrice Severino
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy
| | - Paolo Luciano
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy
| | - Marcello Casertano
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy
| | - Anna Aiello
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy
| | - Gilberto De Nucci
- Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas (UNICAMP), Campinas 13083-970, SP, Brazil
- Correspondence: ; Tel.: +55-19-991788879; Fax: +55-19-32521516
| | - Francesco Frecentese
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy
| |
Collapse
|
|
5
|
Corvino A, Citi V, Fiorino F, Frecentese F, Magli E, Perissutti E, Santagada V, Calderone V, Martelli A, Gorica E, Brogi S, Colombo FF, Capello CN, Araujo Ferreira HH, Rimoli MG, Sodano F, Rolando B, Pavese F, Petti A, Muscará MN, Caliendo G, Severino B. H 2S donating corticosteroids: Design, synthesis and biological evaluation in a murine model of asthma. J Adv Res 2022; 35:267-277. [PMID: 35024201 PMCID: PMC8721254 DOI: 10.1016/j.jare.2021.05.008] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2021] [Revised: 04/27/2021] [Accepted: 05/17/2021] [Indexed: 12/13/2022] Open
Abstract
Introduction Hydrogen sulfide (H2S) is a fundamental biological endogenous gas-mediator in the respiratory system. It regulates pivotal patho-physiological processes such as oxidative stress, pulmonary circulation, airway tone and inflammation. Objectives We herein describe the design and synthesis of molecular hybrids obtained by the condensation of several corticosteroids with different hydrogen sulfide releasing moieties. Methods All the molecules are characterized for their ability to release H2S both via amperometric approach and using a fluorescent probe. The chemical stability of the newly synthesized hybrid molecules has been investigated at differing pH values and in human serum. Results Prednisone-TBZ hybrid (compound 7) was selected for further evaluations. The obtained results from the in vitro and in vivo studies clearly show evidence in favor of the anti-inflammatory properties of the released H2S. Conclusions The protective effect on airway remodeling makes the hybrid Prednisone-TBZ (compound 7) as a promising therapeutic option in reducing allergic asthma symptoms and exacerbations.
Collapse
Affiliation(s)
- Angela Corvino
- Department of Pharmacy, School of Medicine, University of Naples «Federico II», Via D. Montesano, 49, 80131 Napoli, Italy
| | - Valentina Citi
- Department of Pharmacy, University of Pisa, via Bonanno, 6, I-56126 Pisa, Italy
| | - Ferdinando Fiorino
- Department of Pharmacy, School of Medicine, University of Naples «Federico II», Via D. Montesano, 49, 80131 Napoli, Italy
| | - Francesco Frecentese
- Department of Pharmacy, School of Medicine, University of Naples «Federico II», Via D. Montesano, 49, 80131 Napoli, Italy
| | - Elisa Magli
- Department of Pharmacy, School of Medicine, University of Naples «Federico II», Via D. Montesano, 49, 80131 Napoli, Italy
| | - Elisa Perissutti
- Department of Pharmacy, School of Medicine, University of Naples «Federico II», Via D. Montesano, 49, 80131 Napoli, Italy
| | - Vincenzo Santagada
- Department of Pharmacy, School of Medicine, University of Naples «Federico II», Via D. Montesano, 49, 80131 Napoli, Italy
| | - Vincenzo Calderone
- Department of Pharmacy, University of Pisa, via Bonanno, 6, I-56126 Pisa, Italy
| | - Alma Martelli
- Department of Pharmacy, University of Pisa, via Bonanno, 6, I-56126 Pisa, Italy
| | - Era Gorica
- Department of Pharmacy, University of Pisa, via Bonanno, 6, I-56126 Pisa, Italy
| | - Simone Brogi
- Department of Pharmacy, University of Pisa, via Bonanno, 6, I-56126 Pisa, Italy
| | | | | | | | - Maria Grazia Rimoli
- Department of Pharmacy, School of Medicine, University of Naples «Federico II», Via D. Montesano, 49, 80131 Napoli, Italy
| | - Federica Sodano
- Department of Drug Science and Technology, University of Torino, Via Pietro Giuria, 9, 10125 Torino, Italy
| | - Barbara Rolando
- Department of Drug Science and Technology, University of Torino, Via Pietro Giuria, 9, 10125 Torino, Italy
| | - Francesca Pavese
- Genetic S.p.A., Via della Monica, 26 – 84083 Castel San Giorgio (SA), Italy
| | - Antonio Petti
- Genetic S.p.A., Via della Monica, 26 – 84083 Castel San Giorgio (SA), Italy
| | - Marcelo Nicolás Muscará
- Department of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo 05508-000, SP, Brazil
| | - Giuseppe Caliendo
- Department of Pharmacy, School of Medicine, University of Naples «Federico II», Via D. Montesano, 49, 80131 Napoli, Italy
| | - Beatrice Severino
- Department of Pharmacy, School of Medicine, University of Naples «Federico II», Via D. Montesano, 49, 80131 Napoli, Italy
| |
Collapse
|
|
6
|
Magli E, Fattorusso C, Persico M, Corvino A, Esposito G, Fiorino F, Luciano P, Perissutti E, Santagada V, Severino B, Tedeschi V, Pannaccione A, Pignataro G, Caliendo G, Annunziato L, Secondo A, Frecentese F. New Insights into the Structure-Activity Relationship and Neuroprotective Profile of Benzodiazepinone Derivatives of Neurounina-1 as Modulators of the Na +/Ca 2+ Exchanger Isoforms. J Med Chem 2021; 64:17901-17919. [PMID: 34845907 PMCID: PMC8713167 DOI: 10.1021/acs.jmedchem.1c01212] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Due to the neuroprotective role of the Na+/Ca2+ exchanger (NCX) isoforms NCX1 and NCX3, we synthesized novel benzodiazepinone derivatives of the unique NCX activator Neurounina-1, named compounds 1-19. The derivatives are characterized by a benzodiazepinonic nucleus linked to five- or six-membered cyclic amines via a methylene, ethylene, or acetyl spacer. The compounds have been screened on NCX1/NCX3 isoform activities by a high-throughput screening approach, and the most promising were characterized by patch-clamp electrophysiology and Fura-2AM video imaging. We identified two novel modulators of NCX: compound 4, inhibiting NCX1 reverse mode, and compound 14, enhancing NCX1 and NCX3 activity. Compound 1 displayed neuroprotection in two preclinical models of brain ischemia. The analysis of the conformational and steric features led to the identification of the molecular volume required for selective NCX1 activation for mixed NCX1/NCX3 activation or for NCX1 inhibition, providing the first prototypal model for the design of optimized isoform modulators.
Collapse
Affiliation(s)
- Elisa Magli
- Department of Pharmacy, University of Naples "Federico II", Via D. Montesano 49, 80131 Naples, Italy
| | - Caterina Fattorusso
- Department of Pharmacy, University of Naples "Federico II", Via D. Montesano 49, 80131 Naples, Italy
| | - Marco Persico
- Department of Pharmacy, University of Naples "Federico II", Via D. Montesano 49, 80131 Naples, Italy
| | - Angela Corvino
- Department of Pharmacy, University of Naples "Federico II", Via D. Montesano 49, 80131 Naples, Italy
| | - Gianluca Esposito
- Department of Pharmacy, University of Naples "Federico II", Via D. Montesano 49, 80131 Naples, Italy
| | - Ferdinando Fiorino
- Department of Pharmacy, University of Naples "Federico II", Via D. Montesano 49, 80131 Naples, Italy
| | - Paolo Luciano
- Department of Pharmacy, University of Naples "Federico II", Via D. Montesano 49, 80131 Naples, Italy
| | - Elisa Perissutti
- Department of Pharmacy, University of Naples "Federico II", Via D. Montesano 49, 80131 Naples, Italy
| | - Vincenzo Santagada
- Department of Pharmacy, University of Naples "Federico II", Via D. Montesano 49, 80131 Naples, Italy
| | - Beatrice Severino
- Department of Pharmacy, University of Naples "Federico II", Via D. Montesano 49, 80131 Naples, Italy
| | - Valentina Tedeschi
- Department of Neuroscience, Division of Pharmacology, University of Naples "Federico II", via Pansini 5, 80131 Naples, Italy
| | - Anna Pannaccione
- Department of Neuroscience, Division of Pharmacology, University of Naples "Federico II", via Pansini 5, 80131 Naples, Italy
| | - Giuseppe Pignataro
- Department of Neuroscience, Division of Pharmacology, University of Naples "Federico II", via Pansini 5, 80131 Naples, Italy
| | - Giuseppe Caliendo
- Department of Pharmacy, University of Naples "Federico II", Via D. Montesano 49, 80131 Naples, Italy
| | | | - Agnese Secondo
- Department of Neuroscience, Division of Pharmacology, University of Naples "Federico II", via Pansini 5, 80131 Naples, Italy
| | - Francesco Frecentese
- Department of Pharmacy, University of Naples "Federico II", Via D. Montesano 49, 80131 Naples, Italy
| |
Collapse
|
|
7
|
Magli E, Perissutti E, Santagada V, Caliendo G, Corvino A, Esposito G, Esposito G, Fiorino F, Migliaccio M, Scognamiglio A, Severino B, Sparaco R, Frecentese F. H 2S Donors and Their Use in Medicinal Chemistry. Biomolecules 2021; 11:1899. [PMID: 34944543 PMCID: PMC8699746 DOI: 10.3390/biom11121899] [Citation(s) in RCA: 30] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2021] [Revised: 12/09/2021] [Accepted: 12/10/2021] [Indexed: 12/30/2022] Open
Abstract
Hydrogen sulfide (H2S) is a ubiquitous gaseous signaling molecule that has an important role in many physiological and pathological processes in mammalian tissues, with the same importance as two others endogenous gasotransmitters such as NO (nitric oxide) and CO (carbon monoxide). Endogenous H2S is involved in a broad gamut of processes in mammalian tissues including inflammation, vascular tone, hypertension, gastric mucosal integrity, neuromodulation, and defense mechanisms against viral infections as well as SARS-CoV-2 infection. These results suggest that the modulation of H2S levels has a potential therapeutic value. Consequently, synthetic H2S-releasing agents represent not only important research tools, but also potent therapeutic agents. This review has been designed in order to summarize the currently available H2S donors; furthermore, herein we discuss their preparation, the H2S-releasing mechanisms, and their -biological applications.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | | | - Francesco Frecentese
- Department of Pharmacy, School of Medicine, University of Naples Federico II, Via D. Montesano 49, 80131 Napoli, Italy; (E.M.); (E.P.); (V.S.); (G.C.); (A.C.); (G.E.); (G.E.); (F.F.); (M.M.); (A.S.); (B.S.); (R.S.)
| |
Collapse
|
|
8
|
Corvino A, Cerqua I, Lo Bianco A, Caliendo G, Fiorino F, Frecentese F, Magli E, Morelli E, Perissutti E, Santagada V, Cirino G, Granato E, Roviezzo F, Puliti E, Bernacchioni C, Lavecchia A, Donati C, Severino B. Antagonizing S1P 3 Receptor with Cell-Penetrating Pepducins in Skeletal Muscle Fibrosis. Int J Mol Sci 2021; 22:ijms22168861. [PMID: 34445567 PMCID: PMC8396189 DOI: 10.3390/ijms22168861] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2021] [Revised: 08/07/2021] [Accepted: 08/13/2021] [Indexed: 11/25/2022] Open
Abstract
S1P is the final product of sphingolipid metabolism, which interacts with five widely expressed GPCRs (S1P1-5). Increasing numbers of studies have indicated the importance of S1P3 in various pathophysiological processes. Recently, we have identified a pepducin (compound KRX-725-II) acting as an S1P3 receptor antagonist. Here, aiming to optimize the activity and selectivity profile of the described compound, we have synthesized a series of derivatives in which Tyr, in position 4, has been substituted with several natural aromatic and unnatural aromatic and non-aromatic amino acids. All the compounds were evaluated for their ability to inhibit vascular relaxation induced by KRX-725 (as S1P3 selective pepducin agonist) and KRX-722 (an S1P1-selective pepducin agonist). Those selective towards S1P3 (compounds V and VII) were also evaluated for their ability to inhibit skeletal muscle fibrosis. Finally, molecular dynamics simulations were performed to derive information on the preferred conformations of selective and unselective antagonists.
Collapse
Affiliation(s)
- Angela Corvino
- Department of Pharmacy, School of Medicine, University of Naples «Federico II», Via D. Montesano 49, 80131 Napoli, Italy; (A.C.); (I.C.); (A.L.B.); (G.C.); (F.F.); (F.F.); (E.M.); (E.M.); (E.P.); (V.S.); (G.C.); (E.G.); (F.R.); (A.L.)
| | - Ida Cerqua
- Department of Pharmacy, School of Medicine, University of Naples «Federico II», Via D. Montesano 49, 80131 Napoli, Italy; (A.C.); (I.C.); (A.L.B.); (G.C.); (F.F.); (F.F.); (E.M.); (E.M.); (E.P.); (V.S.); (G.C.); (E.G.); (F.R.); (A.L.)
| | - Alessandra Lo Bianco
- Department of Pharmacy, School of Medicine, University of Naples «Federico II», Via D. Montesano 49, 80131 Napoli, Italy; (A.C.); (I.C.); (A.L.B.); (G.C.); (F.F.); (F.F.); (E.M.); (E.M.); (E.P.); (V.S.); (G.C.); (E.G.); (F.R.); (A.L.)
| | - Giuseppe Caliendo
- Department of Pharmacy, School of Medicine, University of Naples «Federico II», Via D. Montesano 49, 80131 Napoli, Italy; (A.C.); (I.C.); (A.L.B.); (G.C.); (F.F.); (F.F.); (E.M.); (E.M.); (E.P.); (V.S.); (G.C.); (E.G.); (F.R.); (A.L.)
| | - Ferdinando Fiorino
- Department of Pharmacy, School of Medicine, University of Naples «Federico II», Via D. Montesano 49, 80131 Napoli, Italy; (A.C.); (I.C.); (A.L.B.); (G.C.); (F.F.); (F.F.); (E.M.); (E.M.); (E.P.); (V.S.); (G.C.); (E.G.); (F.R.); (A.L.)
| | - Francesco Frecentese
- Department of Pharmacy, School of Medicine, University of Naples «Federico II», Via D. Montesano 49, 80131 Napoli, Italy; (A.C.); (I.C.); (A.L.B.); (G.C.); (F.F.); (F.F.); (E.M.); (E.M.); (E.P.); (V.S.); (G.C.); (E.G.); (F.R.); (A.L.)
| | - Elisa Magli
- Department of Pharmacy, School of Medicine, University of Naples «Federico II», Via D. Montesano 49, 80131 Napoli, Italy; (A.C.); (I.C.); (A.L.B.); (G.C.); (F.F.); (F.F.); (E.M.); (E.M.); (E.P.); (V.S.); (G.C.); (E.G.); (F.R.); (A.L.)
| | - Elena Morelli
- Department of Pharmacy, School of Medicine, University of Naples «Federico II», Via D. Montesano 49, 80131 Napoli, Italy; (A.C.); (I.C.); (A.L.B.); (G.C.); (F.F.); (F.F.); (E.M.); (E.M.); (E.P.); (V.S.); (G.C.); (E.G.); (F.R.); (A.L.)
| | - Elisa Perissutti
- Department of Pharmacy, School of Medicine, University of Naples «Federico II», Via D. Montesano 49, 80131 Napoli, Italy; (A.C.); (I.C.); (A.L.B.); (G.C.); (F.F.); (F.F.); (E.M.); (E.M.); (E.P.); (V.S.); (G.C.); (E.G.); (F.R.); (A.L.)
| | - Vincenzo Santagada
- Department of Pharmacy, School of Medicine, University of Naples «Federico II», Via D. Montesano 49, 80131 Napoli, Italy; (A.C.); (I.C.); (A.L.B.); (G.C.); (F.F.); (F.F.); (E.M.); (E.M.); (E.P.); (V.S.); (G.C.); (E.G.); (F.R.); (A.L.)
| | - Giuseppe Cirino
- Department of Pharmacy, School of Medicine, University of Naples «Federico II», Via D. Montesano 49, 80131 Napoli, Italy; (A.C.); (I.C.); (A.L.B.); (G.C.); (F.F.); (F.F.); (E.M.); (E.M.); (E.P.); (V.S.); (G.C.); (E.G.); (F.R.); (A.L.)
| | - Elisabetta Granato
- Department of Pharmacy, School of Medicine, University of Naples «Federico II», Via D. Montesano 49, 80131 Napoli, Italy; (A.C.); (I.C.); (A.L.B.); (G.C.); (F.F.); (F.F.); (E.M.); (E.M.); (E.P.); (V.S.); (G.C.); (E.G.); (F.R.); (A.L.)
| | - Fiorentina Roviezzo
- Department of Pharmacy, School of Medicine, University of Naples «Federico II», Via D. Montesano 49, 80131 Napoli, Italy; (A.C.); (I.C.); (A.L.B.); (G.C.); (F.F.); (F.F.); (E.M.); (E.M.); (E.P.); (V.S.); (G.C.); (E.G.); (F.R.); (A.L.)
| | - Elisa Puliti
- Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence, Viale GB Morgagni 50, 50134 Firenze, Italy; (E.P.); (C.B.); (C.D.)
| | - Caterina Bernacchioni
- Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence, Viale GB Morgagni 50, 50134 Firenze, Italy; (E.P.); (C.B.); (C.D.)
| | - Antonio Lavecchia
- Department of Pharmacy, School of Medicine, University of Naples «Federico II», Via D. Montesano 49, 80131 Napoli, Italy; (A.C.); (I.C.); (A.L.B.); (G.C.); (F.F.); (F.F.); (E.M.); (E.M.); (E.P.); (V.S.); (G.C.); (E.G.); (F.R.); (A.L.)
| | - Chiara Donati
- Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence, Viale GB Morgagni 50, 50134 Firenze, Italy; (E.P.); (C.B.); (C.D.)
| | - Beatrice Severino
- Department of Pharmacy, School of Medicine, University of Naples «Federico II», Via D. Montesano 49, 80131 Napoli, Italy; (A.C.); (I.C.); (A.L.B.); (G.C.); (F.F.); (F.F.); (E.M.); (E.M.); (E.P.); (V.S.); (G.C.); (E.G.); (F.R.); (A.L.)
- Correspondence: ; Tel.: +39-081-679-828
| |
Collapse
|
|
9
|
Magli E, Kędzierska E, Kaczor AA, Bielenica A, Severino B, Gibuła-Tarłowska E, Kotlińska JH, Corvino A, Sparaco R, Esposito G, Albrizio S, Perissutti E, Frecentese F, Leśniak A, Bujalska-Zadrożny M, Struga M, Capasso R, Santagada V, Caliendo G, Fiorino F. Synthesis, docking studies, and pharmacological evaluation of 2-hydroxypropyl-4-arylpiperazine derivatives as serotoninergic ligands. Arch Pharm (Weinheim) 2021; 354:e2000414. [PMID: 33543794 DOI: 10.1002/ardp.202000414] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2020] [Revised: 12/17/2020] [Accepted: 01/08/2021] [Indexed: 01/02/2023]
Abstract
A new series of norbornene and exo-N-hydroxy-7-oxabicyclo[2.2.1]hept-5-ene-2,3-dicarboximide derivatives was prepared, and their affinities to the 5-HT1A , 5-HT2A , and 5-HT2C receptors were evaluated and compared with a previously synthesized series of derivatives characterized by the same nuclei, to identify selective ligands for the subtype receptors. Arylpiperazines represent one of the most important classes of 5-HT1A R ligands, and the research of new derivatives has been focused on the modification of one or more portions of this pharmacophore. The combination of structural elements (heterocyclic nucleus, hydroxyalkyl chain, and 4-substituted piperazine), known to be critical for the affinity to 5-HT1A receptors, and the proper selection of substituents resulted in compounds with high specificity and affinity toward serotoninergic receptors. The most active compounds were selected for further in vivo assays to determine their functional activity. Finally, to rationalize the obtained results, molecular docking studies were performed. The results of the pharmacological studies showed that 3e, 4j, and 4n were the most active and promising derivatives for the serotonin receptor considered in this study.
Collapse
Affiliation(s)
- Elisa Magli
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Ewa Kędzierska
- Department of Pharmacology and Pharmacodynamics, Faculty of Pharmacy with Division of Medical Analytics, Medical University of Lublin, Lublin, Poland
| | - Agnieszka A Kaczor
- Department of Synthesis and Chemical Technology of Pharmaceutical Substances with Computer Modeling Laboratory, Faculty of Pharmacy, Medical University of Lublin, Lublin, Poland.,School of Pharmacy, University of Eastern Finland, Kuopio, Finland
| | - Anna Bielenica
- Department of Biochemistry, Medical University of Warsaw, Warsaw, Poland
| | - Beatrice Severino
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Ewa Gibuła-Tarłowska
- Department of Pharmacology and Pharmacodynamics, Faculty of Pharmacy with Division of Medical Analytics, Medical University of Lublin, Lublin, Poland
| | - Jolanta H Kotlińska
- Department of Pharmacology and Pharmacodynamics, Faculty of Pharmacy with Division of Medical Analytics, Medical University of Lublin, Lublin, Poland
| | - Angela Corvino
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Rosa Sparaco
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Giovanna Esposito
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Stefania Albrizio
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Elisa Perissutti
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Francesco Frecentese
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Anna Leśniak
- Department of Pharmacodynamics, Centre for Preclinical Research and Technology, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland
| | - Magdalena Bujalska-Zadrożny
- Department of Pharmacodynamics, Centre for Preclinical Research and Technology, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland
| | - Marta Struga
- Department of Biochemistry, Medical University of Warsaw, Warsaw, Poland
| | - Raffaele Capasso
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Vincenzo Santagada
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Giuseppe Caliendo
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Ferdinando Fiorino
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| |
Collapse
|
|
10
|
Ferrante MC, Di Vaio P, Magli E, Frecentese F, Meli R, Caliendo G, Corvino A, Fiorino F, Giordano F, Monnolo A, Saccone I, Santagada V, Severino B, Calabria G, Manzo C, Perissutti E. PCB levels in adipose tissue of dogs from illegal dumping sites in Campania region (Italy). Chemosphere 2020; 244:125478. [PMID: 31812762 DOI: 10.1016/j.chemosphere.2019.125478] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/01/2019] [Revised: 11/19/2019] [Accepted: 11/25/2019] [Indexed: 06/10/2023]
Abstract
The aim of the study is to investigate the potential relationship between exposure to PCBs and cancer. In doing so we relied on a sample of dogs coming from a peculiar area of the Campania region (Italy), that has been suffering for illegal waste dumping and open air burning of plastic waste for many years. The latter determined the release of organic and inorganic pollutants, such as the PCBs. By comparing dogs with cancer and healthy dogs, we found much higher PCB concentrations in the former, with a significant difference (p < 0.05) for the non-indicator ∑10NDL-PCB and the DL-PCBs. A regression analysis, controlling for three potentially confounding factors, that are sex, age and weight, confirmed the higher ∑10NDL-PCB concentration in dogs with cancer. Hence, our evidence suggests a potential health hazard for animals and likewise people living in a risky area due to the presence of environmental organic pollutants.
Collapse
Affiliation(s)
- Maria Carmela Ferrante
- Department of Veterinary Medicine and Animal Production, University of Naples Federico II, Via Delpino, 1, 80137, Naples, Italy
| | - Paola Di Vaio
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano, 49, 80131, Naples, Italy
| | - Elisa Magli
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano, 49, 80131, Naples, Italy
| | - Francesco Frecentese
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano, 49, 80131, Naples, Italy
| | - Rosaria Meli
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano, 49, 80131, Naples, Italy
| | - Giuseppe Caliendo
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano, 49, 80131, Naples, Italy
| | - Angela Corvino
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano, 49, 80131, Naples, Italy
| | - Ferdinando Fiorino
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano, 49, 80131, Naples, Italy
| | - Flavia Giordano
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano, 49, 80131, Naples, Italy
| | - Anna Monnolo
- Department of Veterinary Medicine and Animal Production, University of Naples Federico II, Via Delpino, 1, 80137, Naples, Italy
| | - Irene Saccone
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano, 49, 80131, Naples, Italy
| | - Vincenzo Santagada
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano, 49, 80131, Naples, Italy
| | - Beatrice Severino
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano, 49, 80131, Naples, Italy
| | - Giacomo Calabria
- Veterinary Clinic "Giacomo Calabria VET", Via S. Francesco D'Assisi, 41, 80034, Marigliano (NA), Italy
| | - Cosimo Manzo
- Avantech Group s.r.l, Via Masuccio Salernitano, 28, 84012, Angri (SA), Italy
| | - Elisa Perissutti
- Department of Pharmacy, University of Naples Federico II, Via D. Montesano, 49, 80131, Naples, Italy.
| |
Collapse
|
|
11
|
Magli E, Corvino A, Fiorino F, Frecentese F, Perissutti E, Saccone I, Santagada V, Caliendo G, Severino B. Design of Sphingosine Kinases Inhibitors: Challenges and Recent Developments. Curr Pharm Des 2020; 25:956-968. [PMID: 30947653 DOI: 10.2174/1381612825666190404115424] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2019] [Accepted: 03/27/2019] [Indexed: 12/28/2022]
Abstract
BACKGROUND Sphingosine kinases (SphKs) catalyze the phosphorylation of sphingosine to form the bioactive sphingolipid metabolite sphingosine-1-phosphate (S1P). S1P is an important lipid mediator with a wide range of biological functions; it is also involved in a variety of diseases such as inflammatory diseases, Alzheimer's disease and cancer. METHODS This review reports the recent advancement in the research of SphKs inhibitors. Our purpose is also to provide a complete overview useful for underlining the features needed to select a specific pharmacological profile. DISCUSSION Two distinct mammalian SphK isoforms have been identified, SphK1 and SphK2. These isoforms are encoded by different genes and exhibit distinct subcellular localizations, biochemical properties and functions. SphK1 and SphK2 inhibition can be useful in different pathological conditions. CONCLUSION SphK1 and SphK2 have many common features but different and even opposite biological functions. For this reason, several research groups are interested in understanding the therapeutic usefulness of a selective or non-selective inhibitor of SphKs. Moreover, a compensatory mechanism for the two isoforms has been demonstrated, thus leading to the development of dual inhibitors.
Collapse
Affiliation(s)
- Elisa Magli
- Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples, Italy
| | - Angela Corvino
- Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples, Italy
| | - Ferdinando Fiorino
- Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples, Italy
| | - Francesco Frecentese
- Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples, Italy
| | - Elisa Perissutti
- Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples, Italy
| | - Irene Saccone
- Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples, Italy
| | - Vincenzo Santagada
- Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples, Italy
| | - Giuseppe Caliendo
- Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples, Italy
| | - Beatrice Severino
- Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples, Italy
| |
Collapse
|
|
12
|
Magli E, Severino B, Corvino A, Perissutti E, Frecentese F, Saccone I, Giordano F, Castro M, Brea J, Loza MI, Santagada V, Caliendo G, Fiorino F. New Serotoninergic Ligands Containing Indolic and Methyl Indolic Nuclei: Synthesis and In Vitro Pharmacological Evaluation. Med Chem 2019; 16:517-530. [PMID: 31203804 DOI: 10.2174/1573406415666190613153220] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2019] [Revised: 04/23/2019] [Accepted: 04/29/2019] [Indexed: 11/22/2022]
Abstract
BACKGROUND Serotonin is an important biogenic amine and is implicated in wideranging physiological and physiopathological processes. Pharmacological manipulation of the serotoninergic system is believed to have a great therapeutic potential. OBJECTIVES In order to identify selective ligands for 5-HT1A, 5-HT2A and 5-HT2C receptors two series of 4-substituted piperazine derivatives, bearing indolic or methyl indolic nuclei, were synthesized. METHODS All the compounds, synthesized by standard solution methods, were evaluated for 5- HT1A, 5-HT2A and 5-HT2C receptors. The highest affine and selective compounds have been evaluated also on dopaminergic (D1 and D2) and adrenergic (α1A and α2A) receptors. RESULTS Several of the newly synthesized molecules showed affinity in the nanomolar range for 5- HT1A, 5-HT2A and 5-HT2C receptors and moderate to no affinity for other relevant receptors (D1, D2, α1A and α2A). CONCLUSION Compounds 7f and 10a showed a nanomolar affinity towards 5-HT1A with an in vitro pharmacologic profile compatible with antipsychotic drugs.
Collapse
Affiliation(s)
- Elisa Magli
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Beatrice Severino
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Angela Corvino
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Elisa Perissutti
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Francesco Frecentese
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Irene Saccone
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Flavia Giordano
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Marián Castro
- USEF Screening Platform-BioFarma Research Group, Center for Research in Molecular Medicine and Chronic Diseases, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
| | - José Brea
- USEF Screening Platform-BioFarma Research Group, Center for Research in Molecular Medicine and Chronic Diseases, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
| | - María I Loza
- USEF Screening Platform-BioFarma Research Group, Center for Research in Molecular Medicine and Chronic Diseases, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
| | - Vincenzo Santagada
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Giuseppe Caliendo
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Ferdinando Fiorino
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| |
Collapse
|
|
13
|
Severino B, Corvino A, Fiorino F, Frecentese F, Perissutti E, Caliendo G, Santagada V, Magli E, Molinaro P, Pignataro G, Annunziato L, Antunes NJ, Rojas-Moscoso J, de Freitas NL, Mendes GD, De Nucci G. Development, Validation of LC-MS/MS Method and Determination of Pharmacokinetic Parameters of the Stroke Neuroprotectant Neurounina-1 in Beagle Dog Plasma After Intravenous Administration. Front Pharmacol 2019; 10:432. [PMID: 31073288 PMCID: PMC6497007 DOI: 10.3389/fphar.2019.00432] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2018] [Accepted: 04/04/2019] [Indexed: 11/13/2022] Open
Abstract
Neurounina-1 [chemical name: 7-nitro-5-phenyl-1-(pyrrolidin-1-ylmethyl)-1H-benzo[e][1,4]diazepin-2(3H)-one] is a new compound provided with relevant neuroprotective effect during stroke and in neonatal hypoxia by increasing the Na+/Ca2+ exchanger (NCX) isoforms NCX1 and NCX2 activity. This study shows for the first time, the development and validation of a sensitive and selective method for analysis of neurounina-1 in beagle dog plasma by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The sample preparation consisted of extraction of the analyte and the internal standard (IS) (ropivacaine) from plasma (50 μL) by liquid-liquid extraction using acetonitrile (100 μL). The selected reaction monitoring mode of the positive ion was performed and the precursor to the product ion transitions of m/z 365 > 83 and m/z 275 > 126 were used to measure the derivative of neurounina-1 and ropivacaine. The chromatographic separation was achieved using a Phenomenex C18 Luna (150 mm × 4.6 mm × 5 μm) analytical column with an isocratic mobile phase composed of methanol/acetonitrile/water (50/40/10, v/v/v) + 0.1% formic acid + 1 M ammonium formate. The method was linear over a concentration range of 1-500 ng/mL. The method was applied to evaluate the pharmacokinetics of neurounina-1 after a single intravenous administration of three different doses (0.1 mg/kg, 0.3 mg/kg, and 1 mg/kg) to beagle dogs (n = 5). The mean AUC0-tlast values were 26.10, 115.81, and 257.28 ng∗h/mL following intravenous administration of 0.1, 0.3, and 1 mg/kg, respectively. Linear pharmacokinetics was observed up to 1.0 mg/kg. The neurounina-1 was rapidly eliminated, with mean CL values of 46.24, 47.57, and 69.15 L/h, Vd of 130.31, 154.15, and 210.79 L and t1/2 of 2.14, 2.54, and 2.04 h after intravenous administration of 0.1, 0.3, and 1 mg/kg, respectively. This new analytical method allows the rapid determination of the neurounina-1, a new developed compound, able to exert a remarkable neuroprotective effect in the low nanomolar range.
Collapse
Affiliation(s)
- Beatrice Severino
- Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples, Italy
| | - Angela Corvino
- Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples, Italy
| | - Ferdinando Fiorino
- Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples, Italy
| | - Francesco Frecentese
- Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples, Italy
| | - Elisa Perissutti
- Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples, Italy
| | - Giuseppe Caliendo
- Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples, Italy
| | - Vincenzo Santagada
- Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples, Italy
| | - Elisa Magli
- Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples, Italy
| | - Pasquale Molinaro
- Department of Neuroscience, Reproductive and Odontostomatological Sciences, School of Medicine, University of Naples Federico II, Naples, Italy
| | - Giuseppe Pignataro
- Department of Neuroscience, Reproductive and Odontostomatological Sciences, School of Medicine, University of Naples Federico II, Naples, Italy
| | | | - Natalícia J Antunes
- Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas, Campinas, Brazil
| | - Julio Rojas-Moscoso
- Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas, Campinas, Brazil
| | - Noedi L de Freitas
- Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas, Campinas, Brazil
| | - Gustavo D Mendes
- Department of Pharmacology, Faculty of Medical Sciences, Metropolitan University of Santos, Santos, Brazil.,Department of Pharmacology, Faculty of Medicine, São Leopoldo Mandic, Campinas, Brazil.,Faculty of Medicine, University of Mogi das Cruzes, Mogi das Cruzes, Brazil
| | - Gilberto De Nucci
- Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas, Campinas, Brazil.,Department of Pharmacology, Faculty of Medicine, São Leopoldo Mandic, Campinas, Brazil.,Department of Pharmacology, Faculty of Medical Sciences, University of São Paulo, São Paulo, Brazil
| |
Collapse
|
|
14
|
Magli E, Kędzierska E, Kaczor AA, Severino B, Corvino A, Perissutti E, Frecentese F, Saccone I, Massarelli P, Gibuła‐Tarłowska E, Kotlińska JH, Santagada V, Caliendo G, Fiorino F. Synthesis, docking studies, and pharmacological evaluation of 5HT
2C
ligands containing the
N
′‐cyanoisonicotinamidine or
N
′‐cyanopicolinamidine nucleus. Arch Pharm (Weinheim) 2019; 352:e1800373. [DOI: 10.1002/ardp.201800373] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2018] [Revised: 02/07/2019] [Accepted: 02/09/2019] [Indexed: 01/18/2023]
Affiliation(s)
- Elisa Magli
- Dipartimento di FarmaciaUniversità di Napoli “Federico II”Naples Italy
| | - Ewa Kędzierska
- Department of Pharmacology and Pharmacodynamics, Faculty of Pharmacy with Division of Medical AnalyticsMedical University of LublinLublin Poland
| | - Agnieszka A. Kaczor
- Department of Synthesis and Chemical Technology of Pharmaceutical Substances with Computer Modeling Laboratory, Faculty of Pharmacy with Division of Medical AnalyticsMedical University of LublinLublin Poland
- School of PharmacyUniversity of Eastern FinlandKuopio Finland
| | - Beatrice Severino
- Dipartimento di FarmaciaUniversità di Napoli “Federico II”Naples Italy
| | - Angela Corvino
- Dipartimento di FarmaciaUniversità di Napoli “Federico II”Naples Italy
| | - Elisa Perissutti
- Dipartimento di FarmaciaUniversità di Napoli “Federico II”Naples Italy
| | | | - Irene Saccone
- Dipartimento di FarmaciaUniversità di Napoli “Federico II”Naples Italy
| | - Paola Massarelli
- Dipartimento di Scienze Mediche, Chirurgiche e NeuroscienzeUniversità di SienaSiena Italy
| | - Ewa Gibuła‐Tarłowska
- Department of Pharmacology and Pharmacodynamics, Faculty of Pharmacy with Division of Medical AnalyticsMedical University of LublinLublin Poland
| | - Jolanta H. Kotlińska
- Department of Pharmacology and Pharmacodynamics, Faculty of Pharmacy with Division of Medical AnalyticsMedical University of LublinLublin Poland
| | | | - Giuseppe Caliendo
- Dipartimento di FarmaciaUniversità di Napoli “Federico II”Naples Italy
| | | |
Collapse
|
|
15
|
Zaminelli T, Magli E, Frecentese F, Lescano CH, Campos R, Saccone I, Corvino A, Di Vaio P, Giordano F, Luciano P, Fiorino F, Perissutti E, Santagada V, Severino B, Caliendo G, De Nucci G. Synthesis and Pharmacological Screening of Pyridopyrimidines as Effective Anti-Diarrheal Agents through the Suppression of Cyclic Nucleotide Accumulation. ChemistryOpen 2019; 8:464-475. [PMID: 31008011 PMCID: PMC6454219 DOI: 10.1002/open.201900060] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2019] [Revised: 03/12/2019] [Indexed: 11/17/2022] Open
Abstract
The increased levels of cyclic nucleotides (cGMP and cAMP) in enterocytes trigger intracellular mechanisms of ion and fluid secretion into the lumen, causing secretory diarrhea. Twelve novel pyridopyrimidines derived from 5‐(3,5‐bistrifluoromethylphenyl)‐1,3‐dimethyl‐5,11‐dihydro‐1H‐indeno[2,1 : 5,6]pyrido[2,3‐d]pyrimidine‐2,4,6‐trione (FPIPP) were synthesized and evaluated on intracellular cyclic nucleotide accumulation. All compounds had no effect on either cyclic nucleotide basal levels or on pre‐contracted aortic rings. The metabolic activity and viability in T84 cells, assessed by MTT (3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyl tetrazolium bromide) and the LDH (lactate dehydrogenase) assays, respectively, were not affected by incubation with the compounds (50 μM). Compound VI almost abolished cGMP accumulation (94 % inhibition) induced by STa toxin in T834 cells and significantly reduced (69 %) forskolin‐induced cAMP accumulation in Jurkat cells. Compound VI was active in an in vivo model for diarrhea in rabbits. These results prompted us to perform a microscopic histopathological analysis of intestinal tissues, showing that only compound VI preserves the intestine without significant pathological changes and with a decreased inflammatory pattern in comparison to FPIPP. In vitro stability test revealed that compound VI is resistant to oxidation promoted by atmospheric oxygen.
Collapse
Affiliation(s)
- Tiago Zaminelli
- Superior Institute of Biomedical Science Ceará State University (UECE) Ceará Brazil
| | - Elisa Magli
- Department of Pharmacy University of Naples «Federico II» Via D. Montesano, 49 80131 Naples Italy
| | - Francesco Frecentese
- Department of Pharmacy University of Naples «Federico II» Via D. Montesano, 49 80131 Naples Italy
| | - Caroline H Lescano
- Superior Institute of Biomedical Science Ceará State University (UECE) Ceará Brazil
| | - Rafael Campos
- Superior Institute of Biomedical Science Ceará State University (UECE) Ceará Brazil
| | - Irene Saccone
- Department of Pharmacy University of Naples «Federico II» Via D. Montesano, 49 80131 Naples Italy
| | - Angela Corvino
- Department of Pharmacy University of Naples «Federico II» Via D. Montesano, 49 80131 Naples Italy
| | - Paola Di Vaio
- Department of Pharmacy University of Naples «Federico II» Via D. Montesano, 49 80131 Naples Italy
| | - Flavia Giordano
- Department of Pharmacy University of Naples «Federico II» Via D. Montesano, 49 80131 Naples Italy
| | - Paolo Luciano
- Department of Pharmacy University of Naples «Federico II» Via D. Montesano, 49 80131 Naples Italy
| | - Ferdinando Fiorino
- Department of Pharmacy University of Naples «Federico II» Via D. Montesano, 49 80131 Naples Italy
| | - Elisa Perissutti
- Department of Pharmacy University of Naples «Federico II» Via D. Montesano, 49 80131 Naples Italy
| | - Vincenzo Santagada
- Department of Pharmacy University of Naples «Federico II» Via D. Montesano, 49 80131 Naples Italy
| | - Beatrice Severino
- Department of Pharmacy University of Naples «Federico II» Via D. Montesano, 49 80131 Naples Italy
| | - Giuseppe Caliendo
- Department of Pharmacy University of Naples «Federico II» Via D. Montesano, 49 80131 Naples Italy
| | - Gilberto De Nucci
- Superior Institute of Biomedical Science Ceará State University (UECE) Ceará Brazil
| |
Collapse
|
|
16
|
Magli E, Fiorino F, Severino B, Corvino A, Perissutti E, Frecentese F, Giordano F, Saccone I, Luciano P, Zaminelli T, Santagada V, Caliendo G, de Nucci G. Synthesis of phenylpyrimidinones as guanylyl cyclase C inhibitors. Pharmazie 2019; 74:15-17. [PMID: 30782244 DOI: 10.1691/ph.2019.8775] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 09/29/2022]
Abstract
Diarrhea is one of the most important causes of mortality in the developing world, being responsible for 2.5 million deaths each year. Many of these deaths are caused by enterotoxigenic strains of bacteria, like Escherichia coli, that produce enterotoxins that cause acute watery diarrhea, commonly defined as secretory diarrhea. Studies on symptomatic patients indicate a high prevalence of enterotoxigenic E. coli strains producing the heat-stable toxin, STa. STa is a small, cysteine-rich peptide that binds to the extracellular receptor domain of guanylyl cyclase C (GCC), located at the luminal membrane of intestinal epithelial cells. GCC and its endogenous peptide ligands, guanylin and uroguanylin, play a key role in balancing water absorption and hydration of the intestinal lumen, as exemplified by the finding that loss of GCC function causes severe dehydration of the intestinal lumen, culminating in intestinal obstruction. From a mechanistic viewpoint, reduction of GCC activity offers an efficient approach to limit enterotoxigenic E. coli- provoked secretory diarrhea. Inhibition of GCC-mediated cGMP production would not only reduce anion secretion, but would also restore NHE3 activity, resulting in a comprehensive antidiarrheal action. In the present study, two novel phenylpyrimidinone derivatives were simultaneously synthesized and tested for their ability to block STa-induced CFTR activity in T84 cells.
Collapse
|
|
17
|
Corvino A, Fiorino F, Severino B, Saccone I, Frecentese F, Perissutti E, Di Vaio P, Santagada V, Caliendo G, Magli E. The Role of 5-HT1A Receptor in Cancer as a New Opportunity in Medicinal Chemistry. Curr Med Chem 2018; 25:3214-3227. [DOI: 10.2174/0929867325666180209141650] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2017] [Revised: 11/01/2018] [Accepted: 01/31/2018] [Indexed: 11/22/2022]
Abstract
The 5-HT1A receptor is a pharmacologically well characterized serotonin receptor
subtype and it has long been investigated because of its involvement in several physiopathological
mechanisms and treatment of neurological diseases like ansia and depression.
Serotonin (5-HT) also shows many non-neural functions such as essential hypertension, embryogenesis,
follicle maturation and behavior. Moreover, it exerts a growth factor function on
different types of non-tumoral cells, and it was also found to be related to oncogenes. In fact,
growth-stimulatory activity of serotonin in different human tumor cells has been reported. Recently,
new chemical molecules binding the 5-HT1A receptor have been described as novel
therapeutic entities useful in neuroprotection, cognitive impairment, Parkinson’s Disease, pain
treatment, malignant carcinoid syndrome and cancer. It was widely demonstrated that 5-HT1A
receptor is involved in the carcinogenesis and consequently in many human tumor types, such
as prostate, bladder, small cell lung, colonrectal and cholangiocarcinoma. Furthermore, depending
on the tumor type, 5-HT1A receptor antagonists were shown to be capable of blocking
the 5HT-induced increase in tumor growth. In this review, we have focused our attention on
each tumor type where the 5-HT1A receptor is involved, investigating the role of this molecular
target and the different classes of compounds that have shown the capability to modulate it.
The analyzed aspects could represent a hint for the medical chemists to develop novel molecules
as selective 5-HT1A agents are useful in further elucidating the role of this therapeutic
target.
Collapse
Affiliation(s)
- Angela Corvino
- Dipartimento di Farmacia, Universita degli Studi di Napoli Federico II - Via D. Montesano, 49 - 80131, Napoli, Italy
| | - Ferdinando Fiorino
- Dipartimento di Farmacia, Universita degli Studi di Napoli Federico II - Via D. Montesano, 49 - 80131, Napoli, Italy
| | - Beatrice Severino
- Dipartimento di Farmacia, Universita degli Studi di Napoli Federico II - Via D. Montesano, 49 - 80131, Napoli, Italy
| | - Irene Saccone
- Dipartimento di Farmacia, Universita degli Studi di Napoli Federico II - Via D. Montesano, 49 - 80131, Napoli, Italy
| | - Francesco Frecentese
- Dipartimento di Farmacia, Universita degli Studi di Napoli Federico II - Via D. Montesano, 49 - 80131, Napoli, Italy
| | - Elisa Perissutti
- Dipartimento di Farmacia, Universita degli Studi di Napoli Federico II - Via D. Montesano, 49 - 80131, Napoli, Italy
| | - Paola Di Vaio
- Dipartimento di Farmacia, Universita degli Studi di Napoli Federico II - Via D. Montesano, 49 - 80131, Napoli, Italy
| | - Vincenzo Santagada
- Dipartimento di Farmacia, Universita degli Studi di Napoli Federico II - Via D. Montesano, 49 - 80131, Napoli, Italy
| | - Giuseppe Caliendo
- Dipartimento di Farmacia, Universita degli Studi di Napoli Federico II - Via D. Montesano, 49 - 80131, Napoli, Italy
| | - Elisa Magli
- Dipartimento di Farmacia, Universita degli Studi di Napoli Federico II - Via D. Montesano, 49 - 80131, Napoli, Italy
| |
Collapse
|
|
18
|
Justo A, Campos R, Kiguti L, Corvino A, Fiorino F, Frecentese F, Magli E, Perissutti E, Saccone I, De Nucci G. 499 Effect of norbornene derivative in corpus cavernosum relaxation, as 5-HT1A agonist and 5-HT2A antagonist. J Sex Med 2018. [DOI: 10.1016/j.jsxm.2018.04.405] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
|
19
|
Sosic A, Saccone I, Carraro C, Kenderdine T, Gamba E, Caliendo G, Corvino A, Di Vaio P, Fiorino F, Magli E, Perissutti E, Santagada V, Severino B, Spada V, Fabris D, Frecentese F, Gatto B. Non-Natural Linker Configuration in 2,6-Dipeptidyl-Anthraquinones Enhances the Inhibition of TAR RNA Binding/Annealing Activities by HIV-1 NC and Tat Proteins. Bioconjug Chem 2018; 29:2195-2207. [PMID: 29791798 DOI: 10.1021/acs.bioconjchem.8b00104] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The HIV-1 nucleocapsid (NC) protein represents an excellent molecular target for the development of anti-retrovirals by virtue of its well-characterized chaperone activities, which play pivotal roles in essential steps of the viral life cycle. Our ongoing search for candidates able to impair NC binding/annealing activities led to the identification of peptidyl-anthraquinones as a promising class of nucleic acid ligands. Seeking to elucidate the inhibition determinants and increase the potency of this class of compounds, we have now explored the effects of chirality in the linker connecting the planar nucleus to the basic side chains. We show here that the non-natural linker configuration imparted unexpected TAR RNA targeting properties to the 2,6-peptidyl-anthraquinones and significantly enhanced their potency. Even if the new compounds were able to interact directly with the NC protein, they manifested a consistently higher affinity for the TAR RNA substrate and their TAR-binding properties mirrored their ability to interfere with NC-TAR interactions. Based on these findings, we propose that the viral Tat protein, sharing the same RNA substrate but acting in distinct phases of the viral life cycle, constitutes an additional druggable target for this class of peptidyl-anthraquinones. The inhibition of Tat-TAR interaction for the test compounds correlated again with their TAR-binding properties, while simultaneously failing to demonstrate any direct Tat-binding capabilities. These considerations highlighted the importance of TAR RNA in the elucidation of their inhibition mechanism, rather than direct protein inhibition. We have therefore identified anti-TAR compounds with dual in vitro inhibitory activity on different viral proteins, demonstrating that it is possible to develop multitarget compounds capable of interfering with processes mediated by the interactions of this essential RNA domain of HIV-1 genome with NC and Tat proteins.
Collapse
Affiliation(s)
- Alice Sosic
- Dipartimento di Scienze del Farmaco , Università di Padova , via Marzolo 5 , 35131 Padova , Italy
| | - Irene Saccone
- Dipartimento di Farmacia , Università degli Studi di Napoli "Federico II" , Via D. Montesano 49 , 80131 Napoli , Italy
| | - Caterina Carraro
- Dipartimento di Scienze del Farmaco , Università di Padova , via Marzolo 5 , 35131 Padova , Italy
| | - Thomas Kenderdine
- The RNA Institute and Department of Chemistry , State University of New York , 1400 Washington Avenue , Albany , New York 12222 , United States
| | - Elia Gamba
- Dipartimento di Scienze del Farmaco , Università di Padova , via Marzolo 5 , 35131 Padova , Italy
| | - Giuseppe Caliendo
- Dipartimento di Farmacia , Università degli Studi di Napoli "Federico II" , Via D. Montesano 49 , 80131 Napoli , Italy
| | - Angela Corvino
- Dipartimento di Farmacia , Università degli Studi di Napoli "Federico II" , Via D. Montesano 49 , 80131 Napoli , Italy
| | - Paola Di Vaio
- Dipartimento di Farmacia , Università degli Studi di Napoli "Federico II" , Via D. Montesano 49 , 80131 Napoli , Italy
| | - Ferdinando Fiorino
- Dipartimento di Farmacia , Università degli Studi di Napoli "Federico II" , Via D. Montesano 49 , 80131 Napoli , Italy
| | - Elisa Magli
- Dipartimento di Farmacia , Università degli Studi di Napoli "Federico II" , Via D. Montesano 49 , 80131 Napoli , Italy
| | - Elisa Perissutti
- Dipartimento di Farmacia , Università degli Studi di Napoli "Federico II" , Via D. Montesano 49 , 80131 Napoli , Italy
| | - Vincenzo Santagada
- Dipartimento di Farmacia , Università degli Studi di Napoli "Federico II" , Via D. Montesano 49 , 80131 Napoli , Italy
| | - Beatrice Severino
- Dipartimento di Farmacia , Università degli Studi di Napoli "Federico II" , Via D. Montesano 49 , 80131 Napoli , Italy
| | - Valentina Spada
- Dipartimento di Farmacia , Università degli Studi di Napoli "Federico II" , Via D. Montesano 49 , 80131 Napoli , Italy
| | - Dan Fabris
- The RNA Institute and Department of Chemistry , State University of New York , 1400 Washington Avenue , Albany , New York 12222 , United States
| | - Francesco Frecentese
- Dipartimento di Farmacia , Università degli Studi di Napoli "Federico II" , Via D. Montesano 49 , 80131 Napoli , Italy
| | - Barbara Gatto
- Dipartimento di Scienze del Farmaco , Università di Padova , via Marzolo 5 , 35131 Padova , Italy
| |
Collapse
|
|
20
|
Severino B, Corvino A, Fiorino F, Luciano P, Frecentese F, Magli E, Saccone I, Di Vaio P, Citi V, Calderone V, Servillo L, Casale R, Cirino G, Vellecco V, Bucci M, Perissutti E, Santagada V, Caliendo G. 1,2,4-Thiadiazolidin-3,5-diones as novel hydrogen sulfide donors. Eur J Med Chem 2018; 143:1677-1686. [DOI: 10.1016/j.ejmech.2017.10.068] [Citation(s) in RCA: 31] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2017] [Revised: 10/03/2017] [Accepted: 10/24/2017] [Indexed: 11/29/2022]
|
|
21
|
Fiorino F, Magli E, Kędzierska E, Ciano A, Corvino A, Severino B, Perissutti E, Frecentese F, Di Vaio P, Saccone I, Izzo AA, Capasso R, Massarelli P, Rossi I, Orzelska-Gòrka J, Kotlińska JH, Santagada V, Caliendo G. New 5-HT1A, 5HT2A and 5HT2C receptor ligands containing a picolinic nucleus: Synthesis, in vitro and in vivo pharmacological evaluation. Bioorg Med Chem 2017; 25:5820-5837. [DOI: 10.1016/j.bmc.2017.09.018] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2017] [Revised: 09/05/2017] [Accepted: 09/13/2017] [Indexed: 02/02/2023]
|
|
22
|
Frecentese F, Saccone I, Caliendo G, Corvino A, Fiorino F, Magli E, Perissutti E, Severino B, Santagada V. Microwave Assisted Organic Synthesis of Heterocycles in Aqueous Media: Recent Advances in Medicinal Chemistry. Med Chem 2016; 12:720-732. [DOI: 10.2174/1573406412666160502153553] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2015] [Accepted: 04/27/2016] [Indexed: 11/22/2022]
|
|
23
|
Corvino A, Severino B, Fiorino F, Frecentese F, Magli E, Perissutti E, Santagada V, Bucci M, Cirino G, Kelly G, Servillo L, Popowicz G, Pastore A, Caliendo G. Fragment-based de novo design of a cystathionine γ-lyase selective inhibitor blocking hydrogen sulfide production. Sci Rep 2016; 6:34398. [PMID: 27708394 PMCID: PMC5052628 DOI: 10.1038/srep34398] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2016] [Accepted: 09/02/2016] [Indexed: 11/26/2022] Open
Abstract
Hydrogen sulfide is an essential catabolite that intervenes in the pathophysiology of several diseases from hypertension to stroke, diabetes and pancreatitis. It is endogenously synthesized mainly by two pyridoxal-5′-phosphate-dependent enzymes involved in L-cysteine metabolism: cystathionine-ß-synthase (CBS) and cystathionine-γ-lyase (CSE). Research in this field is currently impaired by the lack of pharmacological tools such as selective enzymatic inhibitors that could target specifically only one of these pathways. We used a novel approach based on a hybrid method that includes drug design, synthetic biology, metabolomics and pharmacological assays to rationally design a new inhibitor selective for the CSE enzyme. The identification of this compound opens new frontiers towards a better understanding of the role of CSE over CBS in the pathophysiology of diseases where a role for the H2S pathway has been proposed and the development of new lead compounds that could target the CSE enzyme.
Collapse
Affiliation(s)
- Angela Corvino
- Department of Pharmacy, University of Naples "Federico II" - Via D. Montesano, 49, 80131-Napoli, Italy.,Department of Neuroscience, Wohl Institute, King's College London, Denmark Hill Campus, London SE5, UK
| | - Beatrice Severino
- Department of Pharmacy, University of Naples "Federico II" - Via D. Montesano, 49, 80131-Napoli, Italy
| | - Ferdinando Fiorino
- Department of Pharmacy, University of Naples "Federico II" - Via D. Montesano, 49, 80131-Napoli, Italy
| | - Francesco Frecentese
- Department of Pharmacy, University of Naples "Federico II" - Via D. Montesano, 49, 80131-Napoli, Italy
| | - Elisa Magli
- Department of Pharmacy, University of Naples "Federico II" - Via D. Montesano, 49, 80131-Napoli, Italy
| | - Elisa Perissutti
- Department of Pharmacy, University of Naples "Federico II" - Via D. Montesano, 49, 80131-Napoli, Italy
| | - Vincenzo Santagada
- Department of Pharmacy, University of Naples "Federico II" - Via D. Montesano, 49, 80131-Napoli, Italy
| | - Mariarosaria Bucci
- Department of Pharmacy, University of Naples "Federico II" - Via D. Montesano, 49, 80131-Napoli, Italy
| | - Giuseppe Cirino
- Department of Pharmacy, University of Naples "Federico II" - Via D. Montesano, 49, 80131-Napoli, Italy
| | - Geoff Kelly
- MRC Biomedical NMR Centre, NIMR, NW7 1AA, London
| | - Luigi Servillo
- Department of Biochemistry, Biophysics and General Pathology, Second University of Naples, Italy
| | | | - Annalisa Pastore
- Department of Neuroscience, Wohl Institute, King's College London, Denmark Hill Campus, London SE5, UK
| | - Giuseppe Caliendo
- Department of Pharmacy, University of Naples "Federico II" - Via D. Montesano, 49, 80131-Napoli, Italy
| |
Collapse
|
|
24
|
Zotti AI, Di Gennaro E, Corvino A, Frecentese F, Magli E, Perissutti E, Cirino G, Roviezzo F, Terranova-Barberio M, Iannelli F, Caliendo G, Santagada V, Fiorino F, Budillon A, Severino B. Synthesis of Arylpiperazine Derivatives as Protease Activated Receptor 1 Antagonists and Their Evaluation as Antiproliferative Agents. Anticancer Agents Med Chem 2016; 17:973-981. [PMID: 27671294 DOI: 10.2174/1871520616666160926120904] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2015] [Revised: 07/27/2016] [Accepted: 09/18/2016] [Indexed: 11/22/2022]
Abstract
BACKGROUND Protease activated receptor-1 (PAR1) is a G-coupled receptor activated by α-thrombin and other proteases. Several reports have demonstrated the PAR1 involvement in tumorigenesis and tumor progression. In order to investigate on potential use of PAR1 antagonists as antiproliferative agents. AIMS We have identified a series of arylpiperazine derivatives acting as PAR1 antagonists; the selected molecules have been evaluated for their antiproliferative properties. METHOD All the compounds inhibited the growth of a panel of cell lines expressing PAR1; two of them, compounds 13 and 15, were able to inhibit, in a dose dependent manner, the growth of the selected cell lines with the lowest IC50 values, and were further characterized to define the mechanism responsible for the observed antiproliferative effect. RESULT This study directed us to the identification of two interesting leads that may help to further validate PAR1 as an important therapeutic target for cancer treatment.
Collapse
Affiliation(s)
- Andrea Ilaria Zotti
- Unita di Farmacologia Sperimentale, "Istituto Nazionale dei Tumori Fondazione G. Pascale" -IRCCS - Via M. Semmola, 80131 Naples, Italy
| | - Elena Di Gennaro
- Unita di Farmacologia Sperimentale, "Istituto Nazionale dei Tumori Fondazione G. Pascale" -IRCCS - Via M. Semmola, 80131 Naples, Italy
| | - Angela Corvino
- Dipartimento di Farmacia, Università degli Studi di Napoli «Federico II», Via D. Montesano, 49, 80131, Napoli, Italy
| | - Francesco Frecentese
- Dipartimento di Farmacia, Università degli Studi di Napoli «Federico II», Via D. Montesano, 49, 80131, Napoli, Italy
| | - Elisa Magli
- Dipartimento di Farmacia, Università degli Studi di Napoli «Federico II», Via D. Montesano, 49, 80131, Napoli, Italy
| | - Elisa Perissutti
- Dipartimento di Farmacia, Università degli Studi di Napoli «Federico II», Via D. Montesano, 49, 80131, Napoli, Italy
| | - Giuseppe Cirino
- Dipartimento di Farmacia, Università degli Studi di Napoli «Federico II», Via D. Montesano, 49, 80131, Napoli, Italy
| | - Fiorentina Roviezzo
- Dipartimento di Farmacia, Università degli Studi di Napoli «Federico II», Via D. Montesano, 49, 80131, Napoli, Italy
| | - Manuela Terranova-Barberio
- Unita di Farmacologia Sperimentale, "Istituto Nazionale dei Tumori Fondazione G. Pascale" -IRCCS - Via M. Semmola, 80131 Naples, Italy
| | - Federica Iannelli
- Unita di Farmacologia Sperimentale, "Istituto Nazionale dei Tumori Fondazione G. Pascale" -IRCCS - Via M. Semmola, 80131 Naples, Italy
| | - Giuseppe Caliendo
- Dipartimento di Farmacia, Università degli Studi di Napoli «Federico II», Via D. Montesano, 49, 80131, Napoli, Italy
| | - Vincenzo Santagada
- Dipartimento di Farmacia, Università degli Studi di Napoli «Federico II», Via D. Montesano, 49, 80131, Napoli, Italy
| | - Ferdinando Fiorino
- Dipartimento di Farmacia, Università degli Studi di Napoli «Federico II», Via D. Montesano, 49, 80131, Napoli, Italy
| | - Alfredo Budillon
- Unita di Farmacologia Sperimentale, "Istituto Nazionale dei Tumori Fondazione G. Pascale" -IRCCS - Via M. Semmola, 80131 Naples, Italy
| | - Beatrice Severino
- Department of Pharmacy, University of Naples "Federico II", Via D. Montesano, 49 - 80131- Napoli, Italy
| |
Collapse
|
|
25
|
Frecentese F, Sosic A, Saccone I, Gamba E, Link K, Miola A, Cappellini M, Cattelan MG, Severino B, Fiorino F, Magli E, Corvino A, Perissutti E, Fabris D, Gatto B, Caliendo G, Santagada V. Synthesis and in Vitro Screening of New Series of 2,6-Dipeptidyl-anthraquinones: Influence of Side Chain Length on HIV-1 Nucleocapsid Inhibitors. J Med Chem 2016; 59:1914-24. [PMID: 26797100 DOI: 10.1021/acs.jmedchem.5b01494] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
2,6-Dipeptidyl-anthraquinones are a promising class of nucleic acid-binding compounds that act as NC inhibitors in vitro. We designed, synthesized, and tested new series of 2,6-disubstituted-anthraquinones, which are able to bind viral nucleic acid substrates of NC. We demonstrate here that these novel derivatives interact preferentially with noncanonical structures of TAR and cTAR, stabilize their dynamics, and interfere with NC chaperone activity.
Collapse
Affiliation(s)
- Francesco Frecentese
- Dipartimento di Farmacia, Università di Napoli "Federico II" Via D. Montesano 49, 80131 Napoli, Italy
| | - Alice Sosic
- Dipartimento di Scienze del Farmaco, Università di Padova , via Marzolo 5, 35131 Padova, Italy
| | - Irene Saccone
- Dipartimento di Farmacia, Università di Napoli "Federico II" Via D. Montesano 49, 80131 Napoli, Italy
| | - Elia Gamba
- Dipartimento di Scienze del Farmaco, Università di Padova , via Marzolo 5, 35131 Padova, Italy
| | - Kristina Link
- Dipartimento di Scienze del Farmaco, Università di Padova , via Marzolo 5, 35131 Padova, Italy
| | - Angelica Miola
- Dipartimento di Scienze del Farmaco, Università di Padova , via Marzolo 5, 35131 Padova, Italy
| | - Marta Cappellini
- Dipartimento di Scienze del Farmaco, Università di Padova , via Marzolo 5, 35131 Padova, Italy
| | | | - Beatrice Severino
- Dipartimento di Farmacia, Università di Napoli "Federico II" Via D. Montesano 49, 80131 Napoli, Italy
| | - Ferdinando Fiorino
- Dipartimento di Farmacia, Università di Napoli "Federico II" Via D. Montesano 49, 80131 Napoli, Italy
| | - Elisa Magli
- Dipartimento di Farmacia, Università di Napoli "Federico II" Via D. Montesano 49, 80131 Napoli, Italy
| | - Angela Corvino
- Dipartimento di Farmacia, Università di Napoli "Federico II" Via D. Montesano 49, 80131 Napoli, Italy
| | - Elisa Perissutti
- Dipartimento di Farmacia, Università di Napoli "Federico II" Via D. Montesano 49, 80131 Napoli, Italy
| | - Dan Fabris
- The RNA Institute and Department of Chemistry, State University of New York , 1400 Washington Avenue, Albany, New York 12222, United States
| | - Barbara Gatto
- Dipartimento di Scienze del Farmaco, Università di Padova , via Marzolo 5, 35131 Padova, Italy
| | - Giuseppe Caliendo
- Dipartimento di Farmacia, Università di Napoli "Federico II" Via D. Montesano 49, 80131 Napoli, Italy
| | - Vincenzo Santagada
- Dipartimento di Farmacia, Università di Napoli "Federico II" Via D. Montesano 49, 80131 Napoli, Italy
| |
Collapse
|
|
26
|
Fiorino F, Ciano A, Magli E, Severino B, Corvino A, Perissutti E, Frecentese F, Di Vaio P, Izzo AA, Capasso R, Massarelli P, Nencini C, Rossi I, Kędzierska E, Orzelska-Gòrka J, Bielenica A, Santagada V, Caliendo G. Synthesis, in vitro and in vivo pharmacological evaluation of serotoninergic ligands containing an isonicotinic nucleus. Eur J Med Chem 2016; 110:133-50. [PMID: 26820556 DOI: 10.1016/j.ejmech.2016.01.021] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2015] [Revised: 01/13/2016] [Accepted: 01/14/2016] [Indexed: 01/08/2023]
Abstract
Isonicotinamide derivatives, linked to an arylpiperazine moiety, were prepared and their affinity to 5-HT1A, 5-HT2A and 5-HT2C receptors were evaluated. The combination of structural elements (heterocyclic nucleus, alkyl chain and 4-substituted piperazine) known to play critical roles in affinity for serotoninergic receptors and the proper selection of substituents led to compounds with high specificity and affinity towards serotoninergic receptors. In binding studies, several molecules showed high affinity in nanomolar and subnanomolar range at 5-HT1A, 5-HT2A and 5-HT2C receptors and moderate or no affinity for other relevant receptors (D1, D2, α1 and α2). N-(3-(4-(bis(4-fluorophenyl)methyl)piperazin-1-yl)propyl)isonicotinamide (4s) with Ki = 0.130 nM, was the most active and selective derivative for the 5-HT1A receptor compared to other serotoninergic, dopaminergic and adrenergic receptors. Compound 4o, instead, showed 5-HT2A affinity values in subnamolar range. Moreover, the compounds having better affinity and selectivity binding profile towards 5-HT1A and 5-HT2A receptors were selected in order to be tested by in vitro and in vivo assays to determine their functional activity.
Collapse
Affiliation(s)
- Ferdinando Fiorino
- Dipartimento di Farmacia Università di Napoli "Federico II", Via D. Montesano, 49, 80131, Naples, Italy.
| | - Antonio Ciano
- Dipartimento di Farmacia Università di Napoli "Federico II", Via D. Montesano, 49, 80131, Naples, Italy
| | - Elisa Magli
- Dipartimento di Farmacia Università di Napoli "Federico II", Via D. Montesano, 49, 80131, Naples, Italy
| | - Beatrice Severino
- Dipartimento di Farmacia Università di Napoli "Federico II", Via D. Montesano, 49, 80131, Naples, Italy
| | - Angela Corvino
- Dipartimento di Farmacia Università di Napoli "Federico II", Via D. Montesano, 49, 80131, Naples, Italy
| | - Elisa Perissutti
- Dipartimento di Farmacia Università di Napoli "Federico II", Via D. Montesano, 49, 80131, Naples, Italy
| | - Francesco Frecentese
- Dipartimento di Farmacia Università di Napoli "Federico II", Via D. Montesano, 49, 80131, Naples, Italy
| | - Paola Di Vaio
- Dipartimento di Farmacia Università di Napoli "Federico II", Via D. Montesano, 49, 80131, Naples, Italy
| | - Angelo A Izzo
- Dipartimento di Farmacia Università di Napoli "Federico II", Via D. Montesano, 49, 80131, Naples, Italy
| | - Raffaele Capasso
- Dipartimento di Farmacia Università di Napoli "Federico II", Via D. Montesano, 49, 80131, Naples, Italy
| | - Paola Massarelli
- Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze Università di Siena, Via delle Scotte, 6, 53100, Siena, Italy
| | - Cristina Nencini
- Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze Università di Siena, Via delle Scotte, 6, 53100, Siena, Italy
| | - Ilaria Rossi
- Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze Università di Siena, Via delle Scotte, 6, 53100, Siena, Italy
| | - Ewa Kędzierska
- Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, 20-093 Lublin, Poland
| | - Jolanta Orzelska-Gòrka
- Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, 20-093 Lublin, Poland
| | - Anna Bielenica
- Department of Biochemistry, Medical University of Warsaw, 02-097 Warszawa, Poland
| | - Vincenzo Santagada
- Dipartimento di Farmacia Università di Napoli "Federico II", Via D. Montesano, 49, 80131, Naples, Italy
| | - Giuseppe Caliendo
- Dipartimento di Farmacia Università di Napoli "Federico II", Via D. Montesano, 49, 80131, Naples, Italy
| |
Collapse
|
|
27
|
Severino B, Fiorino F, Corvino A, Caliendo G, Santagada V, Assis DM, Oliveira JR, Juliano L, Manganelli S, Benfenati E, Frecentese F, Perissutti E, Juliano MA. Synthesis, biological evaluation, and docking studies of PAR2-AP-derived pseudopeptides as inhibitors of kallikrein 5 and 6. Biol Chem 2015; 396:45-52. [PMID: 25153237 DOI: 10.1515/hsz-2014-0190] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2014] [Accepted: 07/25/2014] [Indexed: 11/15/2022]
Abstract
A series of protease activated receptor 2 activating peptide (PAR2-AP) derivatives (1-15) were designed and synthesized. The obtained compounds were tested on a panel of human kallikreins (hKLK1, hKLK2, hKLK5, hKLK6, and hKLK7) and were found completely inactive toward hKLK1, hKLK2, and hKLK7. Aiming to investigate the mode of interaction between the most interesting compounds and the selected hKLKs, docking studies were performed. The described compounds distinguish the different human tissue kallikreins with compounds 1 and 5 as the best hKLK5 and hKLK6 inhibitors, respectively.
Collapse
|
|
28
|
Lorenzetti S, Benfenati E, Cozzini P, Dellafiora L, Fiorino F, Ginex T, Giulivo M, La Fauci P, Basile L, Marcoccia D, Perissutti E, Roncaglioni A, Mantovani A. A LIFE-EDESIA project update: An animal-free approach to search for SVHC alternatives. Reprod Toxicol 2015. [DOI: 10.1016/j.reprotox.2015.07.058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
|
29
|
Corvino A, Fiorino F, Frecentese F, Magli E, Perissutti E, Severino B, Bucci MR, Cirino G, Kelly G, Pastore A, Santagada V, Caliendo G. Identification of a novel selective CSE inhibitor through a combined pharmacological and metabolomic approach. Nitric Oxide 2015. [DOI: 10.1016/j.niox.2015.02.089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
|
30
|
Roncaglioni A, Benfenati E, Mantovani A, Fiorino F, Perissutti E, Lorenzetti S. The role of in silico tools in supporting the application of the substitution principle. ALTEX 2015; 32:151-153. [PMID: 25863035 DOI: 10.14573/altex.1503251] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Affiliation(s)
- Alessandra Roncaglioni
- Istituto di Ricerche Farmacologiche "Mario Negri" (IRFMN), Department of Environmental Health Sciences, Laboratory of Environmental Toxicology and Chemistry, Milan, Italy
| | - Emilio Benfenati
- Istituto di Ricerche Farmacologiche "Mario Negri" (IRFMN), Department of Environmental Health Sciences, Laboratory of Environmental Toxicology and Chemistry, Milan, Italy
| | - Alberto Mantovani
- Istituto Superiore di Sanità (ISS), Department of Food Safety and Veterinary Public Health, Rome, Italy
| | - Ferdinando Fiorino
- Università degli Studi di Napoli "Federico II", Department of Pharmacy, Naples, Italy
| | - Elisa Perissutti
- Università degli Studi di Napoli "Federico II", Department of Pharmacy, Naples, Italy
| | - Stefano Lorenzetti
- Istituto Superiore di Sanità (ISS), Department of Food Safety and Veterinary Public Health, Rome, Italy
| |
Collapse
|
|
31
|
Mendes GD, Bittencourt S, Vespasiano CFP, Babadópulos T, Gagliano-Jucá T, Arruda AMM, Perissutti E, Frecentese F, De Nucci G. Propylthiouracil quantification in human plasma by high-performance liquid chromatography coupled with electrospray tandem mass spectrometry: Application in a bioequivalence study. J Chromatogr B Analyt Technol Biomed Life Sci 2014; 969:19-28. [DOI: 10.1016/j.jchromb.2014.07.016] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2013] [Revised: 07/01/2014] [Accepted: 07/13/2014] [Indexed: 11/29/2022]
|
|
32
|
Fiorino F, Magli E, Severino B, Corvino A, Ciano A, Perissutti E, Frecentese F, Massarelli P, Nencini C, Santagada V, Caliendo G. Synthesis andIn VitroPharmacological Evaluation of Novel 2-Hydroxypropyl-4-arylpiperazine Derivatives as Serotoninergic Ligands. Arch Pharm (Weinheim) 2014; 347:698-706. [DOI: 10.1002/ardp.201400174] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2014] [Revised: 06/18/2014] [Accepted: 06/24/2014] [Indexed: 01/10/2023]
Affiliation(s)
- Ferdinando Fiorino
- Dipartimento di Farmacia; Università degli Studi di Napoli “Federico II”; Napoli Italy
| | - Elisa Magli
- Dipartimento di Farmacia; Università degli Studi di Napoli “Federico II”; Napoli Italy
| | - Beatrice Severino
- Dipartimento di Farmacia; Università degli Studi di Napoli “Federico II”; Napoli Italy
| | - Angela Corvino
- Dipartimento di Farmacia; Università degli Studi di Napoli “Federico II”; Napoli Italy
| | - Antonio Ciano
- Dipartimento di Farmacia; Università degli Studi di Napoli “Federico II”; Napoli Italy
| | - Elisa Perissutti
- Dipartimento di Farmacia; Università degli Studi di Napoli “Federico II”; Napoli Italy
| | - Francesco Frecentese
- Dipartimento di Farmacia; Università degli Studi di Napoli “Federico II”; Napoli Italy
| | - Paola Massarelli
- Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze; Università di Siena; Siena Italy
| | - Cristina Nencini
- Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze; Università di Siena; Siena Italy
| | - Vincenzo Santagada
- Dipartimento di Farmacia; Università degli Studi di Napoli “Federico II”; Napoli Italy
| | - Giuseppe Caliendo
- Dipartimento di Farmacia; Università degli Studi di Napoli “Federico II”; Napoli Italy
| |
Collapse
|
|
33
|
Pelà M, Del Zoppo L, Allegri L, Marzola E, Ruzza C, Calo G, Perissutti E, Frecentese F, Salvadori S, Guerrini R. Racemic synthesis and solid phase peptide synthesis application of the chimeric valine/leucine derivative 2-amino-3,3,4-trimethyl-pentanoic acid. Pharmazie 2014; 69:496-499. [PMID: 25073393] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
The synthesis of non natural amino acid 2-amino-3,3,4-trimethyl-pentanoic acid (Ipv) ready for solid phase peptide synthesis has been developed. Copper (I) chloride Michael addition, followed by a Curtius rearrangement are the key steps for the lpv synthesis. The racemic valine/leucine chimeric amino acid was then successfully inserted in position 5 of neuropeptide S (NPS) and the diastereomeric mixture separated by reverse phase HPLC. The two diastereomeric NPS derivatives were tested for intracellular calcium mobilization using HEK293 cells stably expressing the mouse NPS receptor where they behaved as partial agonist and pure antagonist.
Collapse
|
|
34
|
de Moraes FC, Bittencourt SF, Perissutti E, Frencentese F, Arruda AMM, Chen LS, Babadópulos T, De Nucci G. Quantification of dapaconazole in human plasma using high-performance liquid chromatography coupled to tandem mass spectrometry: application to a phase I study. J Chromatogr B Analyt Technol Biomed Life Sci 2014; 958:102-7. [PMID: 24705538 DOI: 10.1016/j.jchromb.2014.01.053] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2013] [Revised: 01/17/2014] [Accepted: 01/24/2014] [Indexed: 11/29/2022]
Abstract
A simple, selective and sensitive method based on high-performance liquid chromatography coupled to tandem mass spectrometry (HPLC-MS/MS) has been developed for the determination of dapaconazole in human plasma using tioconazole as internal standard. The drugs were extracted from plasma by liquid-liquid extraction with ether/hexane (80/20, v/v). The chromatography separation was performed on a Genesis(®) C18 reversed phase analytical column 4μm (100×2.1mm i.d.) with a mobile phase of methanol/acetonitrile/water (80/10/10, v/v/v)+ammonium acetate (0.5mM). Dapaconazole was quantified using a mass spectrometer with an electrospray source in the ESI positive mode (ES+) configured for multiple reaction monitoring (MRM) to monitor the transitions 415.1>159.2 and 387.0>131.0 for dapaconazole and tioconazole, respectively. The method had a chromatography run time of 3.8min and a linear calibration curve over the range 0.2-100ng/mL (r=0.9998). The lower limit of quantification (LLOQ) was 0.2ng/mL. The precision and accuracy values of the assay were within ±10%. The stability tests indicate no significant degradation under the conditions of the experiment. This method was used for a phase I study of topical administration of dapaconazole tosylate in healthy human male volunteers.
Collapse
Affiliation(s)
- Fernanda C de Moraes
- Galeno Research Unit, Latino Coelho St., 1301, Parquel Taquaral, 13087-010 Campinas, SP, Brazil; Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas (UNICAMP), Campinas, SP, Brazil
| | - Samara F Bittencourt
- Galeno Research Unit, Latino Coelho St., 1301, Parquel Taquaral, 13087-010 Campinas, SP, Brazil; Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas (UNICAMP), Campinas, SP, Brazil
| | - Elisa Perissutti
- Department of Pharmaceutical and Toxicological Chemistry, Federico II University, Naples, Italy
| | - Francesco Frencentese
- Department of Pharmaceutical and Toxicological Chemistry, Federico II University, Naples, Italy
| | - André M M Arruda
- Galeno Research Unit, Latino Coelho St., 1301, Parquel Taquaral, 13087-010 Campinas, SP, Brazil
| | - Lu Shi Chen
- Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas (UNICAMP), Campinas, SP, Brazil
| | - Tainah Babadópulos
- Galeno Research Unit, Latino Coelho St., 1301, Parquel Taquaral, 13087-010 Campinas, SP, Brazil
| | - Gilberto De Nucci
- Galeno Research Unit, Latino Coelho St., 1301, Parquel Taquaral, 13087-010 Campinas, SP, Brazil; Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas (UNICAMP), Campinas, SP, Brazil; Department of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, SP, Brazil.
| |
Collapse
|
|
35
|
Fiorino F, Severino B, Magli E, Ciano A, Caliendo G, Santagada V, Frecentese F, Perissutti E. 5-HT(1A) receptor: an old target as a new attractive tool in drug discovery from central nervous system to cancer. J Med Chem 2013; 57:4407-26. [PMID: 24295064 DOI: 10.1021/jm400533t] [Citation(s) in RCA: 73] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
The serotonin receptor subtype 5-HT(1A) was one of the first serotonin receptor subtypes pharmacologically characterized. This receptor subtype has long been object of intense research and is implicated in the pathogenesis and treatment of anxiety and depressive disorders. In recent years, new chemical entities targeting the 5-HT(1A) receptor (alone or in combination with other molecular targets) have been proposed for novel therapeutic uses in neuroprotection, cognitive impairment, Parkinson's disease, pain treatment, malignant carcinoid syndrome, and prostate cancer. This Perspective compares existing data on expression and signaling activity of the 5-HT(1A) receptor to a ligand with an intrinsic agonist or antagonist profile. Our purpose is also to make a complete overview, useful for underlining the features needed to select a specific pharmacological profile rather than another one. This aspect could be really interesting to consider and justify the 5-HT(1A) receptor as a new attractive target for drug discovery.
Collapse
Affiliation(s)
- Ferdinando Fiorino
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II" , Via D. Montesano, 49, 80131, Napoli, Italy
| | | | | | | | | | | | | | | |
Collapse
|
|
36
|
Severino B, Incisivo GM, Fiorino F, Bertolino A, Frecentese F, Barbato F, Manganelli S, Maggioni G, Capasso D, Caliendo G, Santagada V, Sorrentino R, Roviezzo F, Perissutti E. Identification of a pepducin acting as S1P3 receptor antagonist. J Pept Sci 2013; 19:717-24. [PMID: 24133031 DOI: 10.1002/psc.2554] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2013] [Revised: 08/10/2013] [Accepted: 08/19/2013] [Indexed: 12/27/2022]
Abstract
Sphingosine-1-phosphate (S1P) is a bioactive lipid with key functions in the immune, inflammatory, and cardiovascular systems. S1P exerts its action through the interaction with a family of five known G protein-coupled receptors, named S1P(1-5). Among them, S1P(3) has been implicated in the pathological processes of a number of diseases, including sepsis and cancer. KRX-725 (compound 1) is a pepducin that mimics the effects of S1P by triggering specifically S1P(3). Here, aiming to identify novel S1P(3) antagonists, we carried out an alanine scanning analysis to address the contribution of the side chains of each amino acid residue to the peptide function. Then, deleted peptides from both the C- and N-terminus were prepared in order to determine the minimal sequence for activity and to identify the structural requirements for agonistic and, possibly, antagonistic behaviors. The pharmacological results of the Ala-scan derived compounds (2-10) suggested a high tolerance of the pepducin 1 to amino acid substitutions. Importantly, the deleted peptide 16 has the ability to inhibit, in a dose-dependent manner, both pepducin 1-induced vasorelaxation and fibroblast proliferation. Finally, a computational analysis was performed on the prepared compounds, showing that the supposed antagonists 16 and 17 appeared to be aligned with each other but not with the others. These results suggested a correlation between specific conformations and activities.
Collapse
Affiliation(s)
- Beatrice Severino
- Dipartimento di Farmacia, Università di Napoli 'Federico II', Via D. Montesano, 49, 80131, Napoli, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
|
37
|
Sosic A, Frecentese F, Perissutti E, Sinigaglia L, Santagada V, Caliendo G, Magli E, Ciano A, Zagotto G, Parolin C, Gatto B. Design, synthesis and biological evaluation of TAR and cTAR binders as HIV-1 nucleocapsid inhibitors. Med Chem Commun 2013. [DOI: 10.1039/c3md00212h] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
|
38
|
Fiorino F, Eiden M, Giese A, Severino B, Esposito A, Groschup MH, Perissutti E, Magli E, Incisivo GM, Ciano A, Frecentese F, Kretzschmar HA, Wagner J, Santagada V, Caliendo G. Synthesis of benzamide derivatives and their evaluation as antiprion agents. Bioorg Med Chem 2012; 20:5001-11. [DOI: 10.1016/j.bmc.2012.06.026] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2012] [Revised: 05/23/2012] [Accepted: 06/13/2012] [Indexed: 11/25/2022]
|
|
39
|
Caliendo G, Santagada V, Perissutti E, Severino B, Fiorino F, Frecentese F, Juliano L. Kallikrein protease activated receptor (PAR) axis: an attractive target for drug development. J Med Chem 2012; 55:6669-86. [PMID: 22607152 DOI: 10.1021/jm300407t] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Affiliation(s)
- Giuseppe Caliendo
- Dipartimento di Chimica Farmaceutica e Tossicologica, Università degli Studi di Napoli Federico II, Via D. Montesano, 49, 80131, Napoli, Italy.
| | | | | | | | | | | | | |
Collapse
|
|
40
|
Fiorino F, Magli E, Perissutti E, Severino B, Frecentese F, Esposito A, De Angelis F, Incisivo GM, Massarelli P, Nencini C, Di Gennaro E, Budillon A, Di Cintio A, Santagada V, Caliendo G. Synthesis of 1-naphtylpiperazine derivatives as serotoninergic ligands and their evaluation as antiproliferative agents. Eur J Med Chem 2011; 46:2206-16. [DOI: 10.1016/j.ejmech.2011.03.001] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2010] [Revised: 02/11/2011] [Accepted: 03/01/2011] [Indexed: 11/25/2022]
|
|
41
|
Fiorino F, Severino B, De Angelis F, Perissutti E, Magli E, Frecentese F, Esposito A, Massarelli P, Nencini C, Santagada V, Caliendo G. New 5-HT1A receptor ligands containing a N′-cyanoisonicotinamidine nucleus: Synthesis and in vitro pharmacological evaluation. Bioorg Med Chem Lett 2010; 20:2978-82. [DOI: 10.1016/j.bmcl.2010.02.106] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2010] [Revised: 02/25/2010] [Accepted: 02/26/2010] [Indexed: 11/30/2022]
|
|
42
|
Frecentese F, Fiorino F, Perissutti E, Severino B, Magli E, Esposito A, De Angelis F, Massarelli P, Nencini C, Viti B, Santagada V, Caliendo G. Efficient microwave combinatorial synthesis of novel indolic arylpiperazine derivatives as serotoninergic ligands. Eur J Med Chem 2010; 45:752-9. [DOI: 10.1016/j.ejmech.2009.11.023] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2009] [Revised: 11/06/2009] [Accepted: 11/12/2009] [Indexed: 11/30/2022]
|
|
43
|
Fiorino F, Severino B, De Angelis F, Perissutti E, Magli E, Frecentese F, Esposito A, Massarelli P, Nencini C, Viti B, Santagada V, Caliendo G. Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus. Pharmazie 2009; 64:555-564. [PMID: 19827295] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
A series of 4-substituted piperazine derivatives bearing a norbornene nucleus have been prepared and their affinity for serotonin 5-HT1A, 5-HT2A and 5-HT2C receptors has been evaluated. Compounds showing the highest affinity have been selected and evaluated on dopaminergic (D1 and D2) and adrenergic (alpha1 and alpha2) receptors. The combination of structural elements (heterocyclic nucleus, oxyalkyl chain and 4-substituted piperazine) known to be critical in order to have affinity on serotonin receptors and the proper selection of substituents led to compounds with higher receptor specificity and affinity. In binding studies, several molecules showed affinity in nanomolar range towards 5-HT1A, 5-HT2A and 5-HT2C receptors and moderate to no affinity for other relevant receptors (D1, D2, alpha1 and alpha2). Compound 2q 4-[2-[4-(3,4-dichlorophenyl)piperazin-1-yl]ethoxy]-4-aza-tricyclo[5.2.1.02,6]dec-8-ene-3,5-dione (Ki = 1.13 nM), was the most active and selective derivative for the 5-HT2C receptor with respect to other serotonin, dopaminergic and adrenergic receptors. Moreover, compound 3p showed mixed 5-HT2A/5-HT2C activity with affinity values in nanomolar range.
Collapse
MESH Headings
- Animals
- Brain Chemistry/drug effects
- Ligands
- Magnetic Resonance Spectroscopy
- Male
- Norbornanes/chemical synthesis
- Norbornanes/pharmacology
- Radioligand Assay
- Rats
- Rats, Sprague-Dawley
- Receptor, Serotonin, 5-HT1A/chemistry
- Receptor, Serotonin, 5-HT1A/drug effects
- Receptor, Serotonin, 5-HT2A/chemistry
- Receptor, Serotonin, 5-HT2A/drug effects
- Receptor, Serotonin, 5-HT2C/chemistry
- Receptor, Serotonin, 5-HT2C/drug effects
- Receptors, Adrenergic, alpha-1/drug effects
- Receptors, Adrenergic, alpha-1/metabolism
- Receptors, Adrenergic, alpha-2/drug effects
- Receptors, Adrenergic, alpha-2/metabolism
- Receptors, Dopamine D1/chemistry
- Receptors, Dopamine D1/metabolism
- Receptors, Dopamine D2/chemistry
- Receptors, Dopamine D2/metabolism
- Serotonin Agents/chemical synthesis
- Serotonin Agents/pharmacology
Collapse
Affiliation(s)
- F Fiorino
- Dipartimento di Chimica Farmaceutica e Tossicologica, Università degli Studi di Napoli Federico II, Napoli, Italy
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
|
44
|
Severino B, Santagada V, Perissutti E, Fiorino F, Frecentese F, De Angelis F, Esposito A, Caliendo G. Recent Advances in Synthesis of PAR Ligands as Therapeutic Strategy for Inflammatory Diseases. Mini Rev Med Chem 2009; 9:653-63. [DOI: 10.2174/138955709788452711] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
|
45
|
Santagada V, Frecentese F, Perissutti E, Fiorino F, Severino B, Caliendo G. Microwave Assisted Synthesis: A New Technology in Drug Discovery. Mini Rev Med Chem 2009; 9:340-58. [DOI: 10.2174/1389557510909030340] [Citation(s) in RCA: 81] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
|
46
|
Flores Toque HA, Priviero FBM, Teixeira CE, Perissutti E, Fiorino F, Severino B, Frecentese F, Lorenzetti R, Baracat JS, Santagada V, Caliendo G, Antunes E, De Nucci G. Synthesis and pharmacological evaluations of sildenafil analogues for treatment of erectile dysfunction. J Med Chem 2008; 51:2807-15. [PMID: 18393409 DOI: 10.1021/jm701400r] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The 5-[2-ethoxy-5-(4-methylpiperazin-1-ylsulfonyl)phenyl]-1-methyl-3-propyl-1,6-dihydro-7 H-pyrazolo[4,3-d]pyrimidin-7-one, sildenafil, is a cGMP-specific phosphodiesterase-5 (PDE5) inhibitor used for penile erectile dysfunction. In the search for more potent and selective PDE5 inhibitors, new sildenafil analogues (6a-v), characterized by the presence on the sulfonyl group in the 5' position of novel N-4-substituted piperazines or ethylenediamine moiety, were prepared by traditional and microwave-assisted synthesis and tested in rabbit isolated aorta and corpus cavernosum. Similarly to sildenafil, several analogues showed IC50 values in the nanomolar range. In the in vitro studies, all the tested compounds caused concentration-dependent relaxations in both rabbit isolated aorta and corpus cavernosum. All sildenafil analogues potentiated the nitric oxide-dependent vasodilation in endothelium-intact rabbit aorta. Compound 6f exhibited great pEC50 value in corpus cavernosum, and compounds 6r and 6u in isolated aorta were found as potent as sildenafil for inhibiting PDE5. Because several analogues were significantly more lipophilic than sildenafil, these compounds may offer a new lead for development of new sildenafil analogues.
Collapse
Affiliation(s)
- Haroldo A Flores Toque
- Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas, Campinas, Brazil
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
|
47
|
Fiorino F, Severino B, De Angelis F, Perissutti E, Frecentese F, Massarelli P, Bruni G, Collavoli E, Santagada V, Caliendo G. Synthesis andIn-vitroPharmacological Evaluation of New 5-HT1AReceptor Ligands Containing a Benzotriazinone Nucleus. Arch Pharm (Weinheim) 2008; 341:20-7. [DOI: 10.1002/ardp.200700151] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
|
48
|
Perissutti E, Frecentese F, Lavecchia A, Fiorino F, Severino B, De Angelis F, Santagada V, Caliendo G. Design and synthesis of potential β-sheet nucleators via Suzuki coupling reaction. Tetrahedron 2007. [DOI: 10.1016/j.tet.2007.09.071] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
|
49
|
Montes-Gil AC, Zanfolin M, Okuyama CE, Lilla S, Alves DP, Santagada V, Perissutti E, Lavecchia A, Fiorino F, Severino B, Caliendo G, Priviero FBM, Mendes GD, Donato JL, de Nucci G. Pharmacokinetic profile of atenolol aspirinate. Arch Pharm (Weinheim) 2007; 340:445-55. [PMID: 17763375 DOI: 10.1002/ardp.200700070] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
We report microwave-assisted synthetic routes, the pharmacokinetic profile along with results from ulcerogenicity and mutagenicity studies of atenolol aspirinate, and an already described derivative, in which acetyl salicylic acid (aspirin) was connected to atenolol by an ester linkage. Atenolol aspirinate was stable towards aqueous hydrolysis but rapidly hydrolyzed in plasma (t(1/2) = 7.6 min). The results showed that the rapid and complete hydrolysis generates atenolol salicylate, which assumes a conformation stabilized by two intramolecular H-bonds, avoiding its further hydrolysis to salicylic acid and atenolol.
Collapse
Affiliation(s)
- Ana C Montes-Gil
- Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas, Campinas, São Paulo, Brazil
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
|
50
|
D'ursi A, Caliendo G, Perissutti E, Santagada V, Severino B, Albrizio S, Bifulco G, Spisani S, Temussi PA. Conformation-activity relationship of peptide T and new pseudocyclic hexapeptide analogs. J Pept Sci 2007; 13:413-21. [PMID: 17486694 DOI: 10.1002/psc.865] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Peptide T (ASTTTNYT), a segment corresponding to residues 185-192 of gp120, the coat protein of HIV, has several important biological properties in vitro that have stimulated the search for simpler and possibly more active analogs. We have previously shown that pseudocyclic hexapeptide analogs containing the central residues of peptide T retain considerable chemotactic activity. We have now extended the design of this type of analogs to peptides containing different aromatic residues and/or Ser in lieu of Thr. The complex conformation-activity relationship of these analogs called for a reexamination of the basic conformational tendencies of peptide T itself. Here, we present an exhaustive NMR conformational study of peptide T in different media. Peptide T assumes a gamma-turn in aqueous mixtures of ethylene glycol, a type-IV beta-turn conformation in aqueous mixtures of DMF, and a type-II beta-turn conformation in aqueous mixtures of DMSO. The preferred conformations for the analogs were derived from modeling, starting from the preferred conformations of peptide T. The best models derived from the gamma-turn conformation of peptide T are those of peptides XII (DSNYSR), XIII (ETNYTK) and XVI (ESNYSR). The best models derived from the type-IV beta-turn conformation of peptide T are those of peptides XIV (KTTNYE) and XV (DSSNYR). No low-energy models could be derived starting from the type-II beta-turn conformation of peptide T. The analogs with the most favored conformations are also the most active in the chemotactic test.
Collapse
Affiliation(s)
- Annamaria D'ursi
- Dipartimento di Scienze Farmaceutiche, Università di Salerno, 84084-Fisciano Italy
| | | | | | | | | | | | | | | | | |
Collapse
|